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ABSTRACT 
REGULATING GENE EXPRESSION WITH LIGHT-ACTIVATED 
OLIGONUCLEOTIDES 
Julianne C. Griepenburg 
Ivan J. Dmochowski 
 
The work in this thesis identifies new photochemical approaches to gain high 
spatiotemporal control over molecular structure and function, for broad applications in 
materials and biological science. "Caged" compounds provide a method for temporarily 
blocking function until acted upon by an external trigger, typically near-UV light. To 
enable multiplexing studies, three new biomolecular caging strategies were developed 
that can be activated with various wavelengths of near-UV or visible light. The first 
method, an oligonucleotide hairpin structure incorporating one or two nitrobenzyl 
photolinkers, was applied to a miRNA antagomir and used to “turn off” let-7 miRNA in 
zebrafish embryos with 365 nm light. To achieve bidirectional control over miRNA, a 
circular construct was designed for the ability to “turn on” the release of exogenous 
miRNA into zebrafish embryos with 365 nm light. A second oligonucleotide caging 
method, using a ruthenium-based photolinker (RuBEP), was designed to extend 
photoactivation to the visible spectrum, with additional potential for two-photon 
activation. RuBEP was used to cage antisense morpholinos through circularization via a 
Cu(I)-mediated [3+2] Huisgen cycloaddition reaction. RuBEP-caged morpholinos were 
photoactivated to “turn on” antisense activity and successfully knocked down zebrafish 
 v 
 
chd and ntl genes with 450 nm light, with limited background activity prior to irradiation. 
A third method of caging was based on encapsulation within photoresponsive nano-
polymersomes. Self-assembly of nano-polymersomes was optimized to generate visible-
light-responsive vesicles that incorporate a porphyrin dimer in the hydrophobic 
membrane. These nanovesicles were shown to encapsulate a variety of cargo, including 
25mer oligonucleotides, a small molecule fluorescent dye, and two biologically relevant 
metal ions, Zn
2+
 and Ca
2+
. The photoresponsiveness of the system was modulated with 
light wavelength, irradiation time, and the presence of dextran in the aqueous core. 
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Chapter 1 
 
Introduction to light-activation 
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I. "Uncaging" with light 
 The understanding of complex biological systems is advanced by tools that can 
help manipulate structure, function, and or localization of molecules with high spatial and 
temporal resolution. One strategy is to put an active compound under the control of a 
conditional trigger. This concept of blocking a compound's biological activity until acted 
on by an internal or external stimulus was termed "caging" in 1978 by Kaplan et. al. with 
the photolytic release of adenosine 5'-triphosphate.
1
 Light-activation dates back to 1943, 
however, with the example of azobenzene modified amino acids.
2
 Although the term 
"caged" is now widely used in biochemistry, it is somewhat of a misnomer because most 
caging strategies involve the use of one or more small photoactive moieties rather than 
true molecular confinement. 
 Light in the UV to near IR (NIR) window is a commonly used external stimulus 
for the activation of caged molecules as it can be very easily manipulated both temporally 
and spatially. Spatial control depends on the irradiation source and activation wavelength, 
but generally, confocal laser scanning microscopy (CLSM) and two-photon microscopy 
provide excellent and well established spatial resolution with the ability to irradiate and 
image simultaneously. Two-photon microscopy achieves high spatial resolution, with the 
ability to control light in three dimensions down to the sub-cellular level and femtoliter 
volumes.
3,4
  Although UV light has been commonly used for uncaging due to the broad 
availability of UV-active caging groups
5
, uncaging with longer wavelengths of light has 
many potential benefits. Absorption and scattering decrease with increasing wavelength,  
 3 
 
as scattering has a λ-4 dependence on wavelength. Visible light is far less damaging to 
cells than UV light
6
, and has the potential to penetrate biological systems up to 1 cm.
7
 
This makes visible light activation feasible for small biological model systems and cells. 
However, when transitioning to larger biological systems, significantly higher depth 
penetration is necessary. The NIR window (700 - 900 nm) has a very low absorption 
coefficient in biological tissue, and combined with low levels of scattering, NIR light has 
the potential to penetrate tissue to depths of several centimeters.
7
 Above 900 nm, this is 
hindered by strong water absorption. 
 It is important to expand the currently available caging toolkit to include a 
broader range of biologically active molecules that can be controlled light. Specifically, 
there is a need to be able to cage molecules ranging from small metal ions to large 
proteins and plasmids. Additionally, it is of equal importance to expand the wavelengths 
that can be used for uncaging. Several examples exist in the literature for caging moieties 
that can be activated with UV light, but fewer exist for longer wavelength light in the 
visible and near-IR region. Ideally, the future will hold a vast library of caged 
biomolecules that can be activated with high spatiotemporal resolution at different 
wavelengths of light spanning the UV, visible and near-IR spectrum.  
 This introduction will focus on literature precedent for three types of caging 
relevant to the work presented in this thesis: 1) The commonly used UV-active moieties 
and their applications in caging short oligonucleotides, 2) Visible and two-photon light 
activated ruthenium complexes, and 3) Light-responsive polymersomes as nanocarriers. 
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II. Common caging groups 
 Three photoresponsive caging groups that have been commonly used for 
biological applications are nitrobenzyl, coumarin, and azobenzene moieties, shown in 
Figures 1-1, 1-2, and 1-3. These caging groups and their derivatives have received 
attention for their ability to be incorporated site-specifically into biomolecules to control 
structure and function with UV light. 
 The most commonly used caging group
8
, and the caging group used most 
frequently in our laboratory is the nitrobenzyl group, shown in Figure 1-1. The ortho-
nitrobenzyl has been widely used as a synthetic protecting group since initial reports in 
1970.
9,10
 Ortho-nitrobenzyl is photoactive at 365 nm, but the wavelength can be tuned by 
adding substituents. Common derivatives of 2-nitrobenzyl are the 4,5-dimethoxy analog 
(DMNB), 1-(2-nitrophenyl)ethyl (NPE) and 4,5-dimethoxy analog (DMNPE) and α-
carboxy analog (CNB) which range in activation wavelength from 260 nm to 365 nm.
11
  
These analogs provide benefits and drawbacks, for example, CNB has increased 
hydrophilicity due to the carboxy groups, but activates at shorter wavelengths (maximum 
at 260 nm).
12
  DMNPE and DMNB activate at longer wavelengths (maximum at 355 
nm), but photolysis rates and quantum yields are typically much lower than for CNB. 
Recently, styryl-2-nitrobenzyl (SNB) moieties were presented to extend conjugation and 
red-shift activation wavelengths to 370 nm, allowing tail-end activation up to 450 nm.
13
 
The nitrobenzyl moiety has become so widely used for photocontrol over 
oligonucleotides, that a phosphoramidite was made that can be directly incorporated into 
 5 
 
solid-phase synthesis,
14,15
 and is now commercially available through Glen Research 
(Sterling, VA). 
 Initial literature on coumarin protecting groups dates back to 1984 with the report 
on 7-methoxycoumarin-4-ylmethyl (MCM) esters by Givens et al.
16
 Irradiation of 
coumarin results in the release of the protected carboxylic acid and formation of the 
corresponding hydroxymethyl coumarin. Typical MCM esters have activation 
wavelengths in the UV (340 - 360 nm) range, but the spectral range of irradiation can be 
altered with the addition of substituents, which can also change the hydrophilicity and 
quantum yield of photolysis. Brominated 7-hydroxycoumarin-4-ylmethyl esters (Bhc) is a 
coumarin derivative reported by Furuta et al. that has been modified to push the 
activation wavelength to 365 nm. Additionally,  the extended conjugation and high 
extinction coefficient for π-π* transitions makes Bhc two-photon active with a cross 
section of 1 GM.
17
 This two-photon active coumarin has been applied to the design and 
synthesis of a caged glutamate and used to resolve three-dimensional maps of neuron 
glutamate sensitivity in intact mouse brain slices.
17
 Structures of coumarin (MCM ester) 
and derivative Bhc are shown in Figure 1-2. Recently, coumarin derivatives have been 
synthesized for photoactivation with visible light. Variations of (coumarin-4-
yl)methoxycarbonyl (CMOC) have been shown to light-activate in the visible region, and 
by adding carboxylate substituents, these chromophores can be made more water 
soluble,
18
 which makes them candidates for biological applications.
19
 
 6 
 
 Azobenzene is another popular choice as a photoactive moiety that has a different 
light-activated mechanism than other caging groups. Azobenzene undergoes trans-cis 
isomerization upon irradiation with UV light, resulting in a structural change instead of 
photocleavage. Unlike the previously presented groups, nitrobenzyl and coumarin, 
azobenzene has the ability to "photoswitch" and reverse back to trans, initiated either 
thermally or upon irradiation with visible light. Many derivatives have been made to 
adjust the wavelength, quantum yield, and to prevent the thermally activated 
isomerization back to the trans configuration to have better control over the system with 
light.
20
 Several examples in the literature have used azobenzene, from the reversible 
photocontrol of oligonucleotide duplex formation,
21-23
 to the incorporation of azobenzene 
derivatives in diblock copolymers for materials science applications.
24-26
 The reversible 
isomerization of azobenzene is shown in Figure 1-3.  
 
III. Light-activated oligonucleotides 
 Caging a wide variety of small and large biologically active molecules has been a 
popular area of research and has had much success in recent years. Examples of caging 
can be found for molecules including metal ions,
27
 peptides,
28
 oligonucleotides,
29
 
proteins,
30
 and plasmids.
31,32
 This review will focus on literature pertaining to caging 
short oligonucleotides that control gene expression, primarily antisense oligonucleotides.  
 Over the past two decades, several methods for controlling oligonucleotide 
function with light have been developed.
29
 Caging oligonucleotides is challenging due to 
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their complexity and large size, and thus, many different methods have been explored. 
Initial efforts towards light-activated oligonucleotides were made in 1995 by 
Ordoukhanian et. al., with the design of photoresponsive DNA "building blocks" which 
could be site-specifically incorporated into a short oligonucleotide synthesis, and 
destabilize hybridization upon photolysis with 355 nm light.
33
 Another example of using 
photoresponsive nucleobases to induce DNA strand breaks was presented in 2002 by 
Dussy et. al.
34
 More commonly, strategies have been developed that involve the use of 
caging groups on the nucleosides to disrupt Watson-Crick base pairing and destabilize 
duplex formation until irradiation.
35,36
 This strategy has been used widely for a variety of 
applications including siRNA,
37-39
 peptide nucleic acids,
40,41
 caged fluorescent 
oligonucleotides,
42
 antisense oligonucleotides,
43-45
 and miRNA.
43,46
 A cartoon 
representation of these designs is represented in Figure 1-4 A-B. 
 Although caged nucleobases have proven effective towards light-activating 
hybridization based functions of oligonucleotides, drawbacks of this approach include the 
need for unique nucleobase monomers, which makes it difficult to design a generalizable 
method for caging. Another drawback to this method is that typically multiple caging 
groups are necessary to effectively disrupt hybridization which increases the light dose 
necessary for uncaging. This can be especially problematic since many of these designs 
use UV-active moieties, and high doses of UV irradiation can be damaging in biological 
systems. For these reasons, our lab and others have moved towards caged hairpin and 
circular caged designs. 
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A. Caged hairpin oligonucleotides 
 Caged hairpins consist of a biologically active strand and a shorter 
complementary strand, covalently attached with one or more photocleavable linkers. 
Through hybridization of a shorter blocking strand, the biologically active strand is 
rendered inactive. Covalent attachment of the two complementary sequences achieves a 
higher effective concentration, resulting in a higher thermal stability for the duplex. 
While covalently held in the hairpin structure, the biologically active strand is unable to 
bind to its target. Upon irradiation with UV light, the photolinker is cleaved which 
destabilizes the duplex. This results in duplex dissociation, and more favorable 
hybridization to the full length target. A schematic representation of a caged hairpin is 
shown in Figure 1-6A. 
 Our lab has designed and synthesized various caged hairpins, for RNase H-
mediated mRNA digestion, antisense oligonucleotides, and most recently, for harvesting 
mRNA from single cells.
47
 Additional examples for caged hairpins have been presented 
by the Chen lab.
48-50
 One of the first examples published by Tang and Dmochowski 
reported a caged antisense DNA hairpin.
51
 This hairpin blocked function of a 20-mer 
DNA when covalently attached to a blocking strand via a nitrobenzyl-based 
heterobifunctional photocleavable linker. Upon photocleavage with 365 nm light, 
antisense DNA was revealed to bind to target mRNA and recruit RNase H for mRNA 
degradation. This design was applied to target c-myb, a hematopoietic transcription factor 
in human K562 (leukemia) cells.
52
 A similar design was applied to caging an 18-mer 
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antisense negatively charged peptide nucleic acid.
53
 This caged antisense hairpin was 
used to photomodulate gene expression in zebrafish embryos for two early developmental 
genes, chordin and bozozok. 
 Additional efforts have been made towards caging antisense morpholinos, which 
are currently the gold standard in achieving gene knockdown in many model 
developmental organisms, including sea urchin, ascidian, zebrafish, frog, chick, and 
mouse.
54
 Morpholinos (Figure 1-5) have been demonstrated to have high nuclease 
resistance due to their highly modified backbone. Initial reports of caging morpholinos by 
Shestopalov et al. involved a hairpin structure, where the morpholino, inhibitor sequence 
and dimethoxynitrobenzyl moiety were linked through a Cu(I)-catalyzed Huisgen 1,3-
dipolar cycloaddition.
48
 Additional features of this design included 3′ fluorescein for 
construct visualization in vivo. Successful photomodulation of zebrafish notail was 
achieved with this design. Following up on this design, Shestopalov et al. reported an 
additional caged morpholino with a simplified synthesis.
49,50
 A DMNB-based 
bifunctional linker was used to conjugate the antisense morpholino and its 
complementary inhibitor strand in three steps, starting with commercially available 
morpholinos. Generalizable methods pertaining to inhibitor placement and length 
optimization were also explored. Additionally, a bromohydroxyquinoline (BHQ)-based 
linker for two-photon uncaging was presented. 
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B. Circular caged oligonucleotides 
 More recently, caging of short oligonucleotides has been achieved through 
circularization.
55-59
 By covalently attaching the 5′ and 3′ ends of the oligonucleotide with 
a photocleavable linker so that it forms a circular structure, the oligonucleotide is 
structurally restricted from hybridizing to a complementary target. A cartoon 
representation of this design is shown in Figure 1-6. This design has many benefits that 
arise from the lack of a blocking sequence. Primarily, the circularization scheme is 
sequence independent. Additionally, there is no risk of the blocking strand having 
biological activity and off-target effects after photolysis and dissociation. As there is only 
one photocleavable linker in most circular designs, this significantly lowers the light dose 
necessary for uncaging. 
 Initial reports of circular oligonucleotides were by Richards et al. where a 
photolabile circular DNAzyme was enzymatically synthesized using T4 ligase and 
photomodulation of RNA digestion was achieved.
58
 Tang et al. presented the first 
example of photomodulating RNA digestion by RNase H through the synthesis of light-
activated circular DNA antisense oligonucleotides.
57
 The first example of a caged circular 
morpholino was reported by Yamazoe et al.,
55
 shortly followed by Wang et al. who also 
caged a 25-mer morpholino by linking the two ends in a circular structure with a 
nitrobenzyl photocleavable moiety.
56
 These caged cMOs were successfully used to 
photomodulate early developmental genes in zebrafish embryos with 365 nm light. 
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Yamazoe et al. compared background activity between  circular and hairpin structures 
and found significantly less background activity in vivo with circular constructs.  
 
C. Other designs of caged oligonucleotides 
 Another method for caging oligonucletides reported by the Dmochowski lab is an 
"RNA bandage" design that provides a method of blocking mRNA translation and 
restoring it upon irradiation with UV light.
60
 These constructs perform opposite of the 
previously described caged hairpins and circular caged oligonucleotides, as they can 
regulate gene expression from "off to on" as opposed to "on to off". A schematic 
representation is shown in Figure 1-7A. Bandages were designed and synthesized using 
2′-OMe RNA antisense oligonucleotides and linked by a nitrobenzyl-based 
photocleavable moiety that activates with 365 nm irradiation. These RNA bandages were 
demonstrated to be successful at photomodulating in vitro translation.  
 A similar design strategy was implemented by Tallafuss et al. to cage an antisense 
morpholino.
61
 In this design, two shorter blocking sequences were linked with a 
nitrobenzyl photocleavable moiety and hybridized to a 25-mer target morpholino for 
turning genes from "off to on" with light (Figure 1-7A). Additionally, this design can be 
used for "on to off" gene photomodulation by linking two shorter MO sequences together 
with a nitrobenzyl moiety to form a full length active morpholino that is able to bind to 
an mRNA target (Figure 1-7B). Upon UV light exposure, the two shorter MO sequences 
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are liberated, resulting in dissociation from the mRNA. This technology is commercially 
available through Gene Tools (Philomath, Oregon). 
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Figure 1-1. Structure of o-nitrobenzyl and derivatives 
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Figure 1-2. Structure of MCM ester (coumarin) and derivative, brominated 7-
hydroxycoumarin-4-ylmethyl ester (Bhc). 
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Figure 1-3. Azobenzene structure   
Azobenzene changes from trans-cis configuration upon UV irradiation and cis-trans thermally, or 
upon visible irradiation. 
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Figure 1-4. Cartoon representation of A) caged backbone, or photocleavable bases and B) 
caged nucleobases.  
A) The oligonucleotide hybridizes to the target (depicted as mRNA) until irradiated with UV 
light. B) Caging groups on bases disrupt Watson-Crick base pairing until irradiation with UV 
light. Caging groups are shown in red, antisense oligonucleotide sequence is shown in green, and 
target (mRNA) is shown in gray. 
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Figure 1-5. Structure of antisense morpholino 
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Figure 1-6. Cartoon representation of A) caged antisense hairpin and B) circular antisense 
oligonucleotide.  
A) An antisense sequence is covalently attached to a blocking sequence by a photocleavable 
linker. This blocking sequence can vary in length and placement. B) An antisense sequence is 
covalently held in a circular structure to prevent target binding. Upon UV irradiation, the 
antisense oligonucleotide is liberated and able to hybridize to a complementary target. Caging 
groups are shown in red, antisense oligonucleotide sequence is shown in green, blocking 
sequence is shown in blue, and target (mRNA) is shown in gray. 
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Figure 1-7. Cartoon representation of A) RNA bandage or Photomorph and B) Photomorph 
"off to on" antisense oligonucleotide.  
A) Two shorter antisense sequences are joined by a photocleavable group to form a full length 
sequence that can hybridize to target mRNA. Upon irradiation, shorter sequences dissociate and 
liberate mRNA. B) Two shorter blocking sequences are joined by a photocleavable group to form 
a full length sequence that can hybridize block morpholino function. Upon irradiation, shorter 
sequences dissociate and activate the morpholino. Caging groups are shown in red, antisense 
oligonucleotide sequence is shown in green, blocking sequence is shown in blue, and target 
(mRNA) is shown in gray. 
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III. Moving away from ultraviolet light activation 
 
A. One-photon vs. two-photon activation 
 The primary goal of caged compounds is the ability to control biological 
processes with light with high spatiotemporal resolution. Although much progress has 
been made towards this goal through the use of 1-photon active moieties such as the UV 
active o-nitrobenzyl group and derivatives, significant improvements can be achieved 
with the implementation of two-photon photolinkers. The use of 2-photon activation in 
caged compounds can provide even greater spatial resolution in three dimensions through 
the addition of depth control.
62
   
 Two-photon photolysis replaces the absorption of one photon with two longer-
wavelength, lower-energy photons, typically in the NIR region, of equivalent total 
energy. The simultaneous absorption of these photons is governed by the light intensity 
and the two-photon absorption cross section, measured in GM (Göppert-Mayer). A GM is 
equal to 10
-50
cm
4 
s photon
-1
, therefore,
 
confining the uncaging event to a very small 
region of focus with negligible out of focus irradiation.
63
  This allows for uncaging in 
very small regions of interest and volumes as small as 1 femtoliter.
4
  Additional benefits 
of NIR light used for two-photon uncaging is significantly less scattering than shorter 
wavelength light, and  less damage to biological systems compared to UV light.
64
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B. Two-photon photolinkers 
 Nitrobenzyl and coumarin derivatives have been shown to be two-photon active, 
however their two-photon absorption cross sections are very low, in the 0.01 - 0.1 GM 
range.
65
 Although NIR light is significantly less damaging than UV light, high laser 
powers required to activate compounds with such low two-photon cross sections result in 
heating and toxicity due to water strongly absorbing 700-900 nm light.
66
 For this reason, 
it is necessary to develop two-photon caging groups with significantly higher cross-
sections (3-30 GM).
63
 
 There are few applications that have been demonstrated for two-photon caged 
biomolecules, likely due to the limited availability of two-photon caging groups. Some 
examples of two-photon caged compounds using coumarin derivatives are caged calcium, 
azid-1,
67
 and caged glutamate.
68
 Although successful two-photon uncaging has been 
achieved with these caged compounds,
69,70
 cross-sections were measured to be below the 
3 - 30 GM target level, therefore requiring high levels of laser power.
4
   
 
C. [Ru(bpy)2XY]
n+ 
ligand dissociation with visible and two-photon light 
 Octahedral Ru(II) polypyridyl complexes have been shown to be a promising 
method of caging molecules for release with visible and two-photon excitation. 
Specifically, complexes of the type [Ru(bpy)2XY]
n+
, a Ru(II) center with two bipyridines 
and two monodentate ligands (Figure 1-8), undergo photochemistry resulting in the 
photodissociation of one or both monodentate ligands.
71
 Initial reports of these complexes 
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were published by Dwyer et al.,
72
 with in-depth photochemical studies followed two 
decades later.
73
 Photochemical reactions typically follow equation (1) and sometimes also 
equation (2), where X and Y are monodentate ligands, and S is solvent. 
          
                 
           
          
                 
          
 A general mechanism of photorelease is demonstrated through the Jablonski 
diagram in Figure 1-9. Upon irradiation, absorption into the MLCT (typically 400-500 
nm) populates the single 
1
MLCT band. Intersystem crossing (ISC) occurs, populating the 
triplet 
3
MLCT state. This process occurs very rapidly, on the order of 40 fs measured for 
Ru(bpy)3
2+
.
74
 Decay can occur through multiple pathways, non-radiative (nr), radiative 
(rad), and in the case of [Ru(bpy)2XY]
n+
, cross-over to the ligand field (
3
LF) state where 
ligand dissociation occurs.
75
 Population of the ligand field state is thermally activated, 
and directly correlates with the energy gap between 
3
MLCT and 
3
LF. At a given 
temperature, a higher energy 
1
MLCT results in a higher energy 
3
MLCT band and thus, a 
smaller gap between 
3
MLCT and 
3
LF. This results in a blue-shifted MLCT ground-state 
absorption band and therefore, a higher yield of photosubstitution (i.e., a higher quantum 
yield). In contrast, a larger gap between the 
3
MLCT and 
3
LF will result in lower quantum 
yields of photosubstitution.
75
 
 
h 
h 
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D. [Ru(bpy)2(X)2]
2+
 as a photolinker 
 The tunable photophysical properties of [Ru(bpy)2XY]
n+ 
make these complexes 
very attractive for caging applications. The MLCT in the visible region is beneficial for 
use in biological systems, as visible light is far less damaging to cells, and also penetrates 
tissue samples deeper due to the longer wavelength.
71
 Additionally, as shown in Scheme 
1-1, the mechanism of uncaging is through a ligand-exchange process instead of a photo-
cleavage process which allows for very clean and efficient whole-molecule uncaging. 
Many examples of whole-molecule caging with these ruthenium complexes have been 
presented in the literature.  
 The first example of ruthenium caging of a biologically relevant molecule was 
presented by Zayat et. al. in 2003 with the caging of 4-aminopyridine.
76
 In this example, 
4-aminopyridine (4-AP), a neurocompound that blocks K
+
 channels,
77
 was cooordinated 
directly to Ru(bpy)2Cl2 through the amine. The resulting water-soluble compound, 
[Ru(bpy)2(4-AP)2]Cl2 had a MLCT centered at 489 nm and underwent successful 
uncaging, as confirmed by a free 4-AP ligand seen by 
1
H NMR spectroscopy. 
Experiments using [Ru(bpy)2(4-AP)2]Cl2 showed successful uncaging and neuronal 
stimulation in a leech ganglion, with no toxicity observed. Additional compounds were 
designed by the Etchenique lab using similar strategies, including a cholinergic agonist 
nicotine, [Ru(bpy)2(Nic)2]
2+
,
78
 and a caged γ-aminobutyric acid (GABA).79 These caged 
compounds all coordinated to the ruthenium through an amine. 
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 The octahedral ruthenium center on [Ru(bpy)2XY]
n+ 
provides flexibility in 
coordination chemistry. The choice of ligand depends primarily on the desired 
photophysical characteristics, such as wavelength and quantum yield, providing excellent 
potential for designing photolinkers. Selecting ligands that are much weaker σ-donors 
will result in an electronically depleted Ru(II) center, thus, shifting the activation to 
higher energy (shorter wavelengths). This blue-shifting results in a significantly higher 
quantum yield.
80
 Another consideration is whether or not one or both monodentate 
ligands will dissociate. This also depends on the electronics of the ligands. For example, 
if X and Y are different ligands, substitution will occur at the ligand that is a weaker σ-
donor. In cases where the monodentate ligands are identical, the substitution will proceed 
on one ligand to form the mono-aquo product, unless the ligand is a weaker σ-donor than 
the solvent, in which case both ligands will be exchanged.
71
  
 Another benefit of using [Ru(bpy)2XY]
n+ 
compounds as photolinkers is their 
demonstrated two-photon activation. Salierno et al. presented a caged glutamate, 
Ru(bpy)2(PMe3)(Glu), which could be efficiently uncaged with one-photon (450 nm) or 
two-photon (800 nm) light.
81
 The two-photon cross section for this caged glutamate was 
determined to be 0.14 GM. Additional examples of two-photon activation of 
[Ru(bpy)2XY]
n+ 
compounds include the two-photon uncaging of a caged dopamine, 
[Ru(bpy)2(PMe3)(Dopa)](PF6)2 which has an even higher two-photon cross-section of 
0.24 GM.
82
 These two-photon cross sections are significantly higher than what has been 
reported for two-photon activation of nitrobenzyl or coumarin derivatives, and there.is 
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potential for tuning the Ru ligands to achieve the desired 3-30 GM target.  Compounds of 
the type [Ru(bpy)2XY]
n+ 
are promising for developing a library of photoactive moieties, 
as they are widely tunable depending on the coordinated ligands.  
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Figure 1-8. General structure of [Ru(bpy)2XY]
n+
 complexes 
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Figure 1-9. Jablonski diagram showing mechanism of photo-triggered ligand dissociation 
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Scheme 1-1. General scheme for single ligand exchange of [Ru(bpy)2XY]
n+
 in H2O 
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IV. Light-activated polymersomes 
 
A. Introduction to polymersomes 
 Polymersomes are a class of synthetic vesicles that self-assemble from 
amphiphilic diblock copolymers.
83
  Polymersomes have attracted much attention since 
their initial discovery by Hammer, Discher, and Eisenberg a little over a decade ago
84,85
 
due to their robustness, tunability, ability to mimic biological membranes and the ability 
to encapsulate a broad variety of molecules. Polymersomes are composed of two 
components, a large hollow aqueous core, and a thick hydrophobic membrane which 
separates the aqueous core from the outer medium. These two structural components 
provide versatility in encapsulation possibilities, from hydrophobic drugs (ie, paclitaxel, 
doxorubicin, quantum dots) encapsulated in the membrane, to small molecules and large 
biomolecules (i.e., siRNA, DNA, plasmids, proteins, enzymes) encapsulated in the 
aqueous core. 
 Polymersomes have many benefits over liposomes as carrier systems, namely,  
they are fully synthetic which provides the possibility to tune many characteristics such 
as membrane thickness, vesicle size, and vesicle composition. Since polymersomes are 
comprised of high molecular weight polymers as opposed to small phospholipids like 
liposomes, membrane thickness typically spans from 3-30 nm in comparison to 3-5 nm.
83
 
These high molecular weights also offer benefits such as decreased membrane 
permeability and enhanced mechanical strength. Additionally, polymersomes have been 
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shown to have significantly longer circulation times in vivo than unmodified liposomes.
86
 
Circulation time of liposomes is typically on the order of hours,
87
 but can be increased by 
functionalizing the outer surface with poly(ethylene glycol) (PEG), known as "stealth 
liposomes".
88
 In contrast, polymersomes have intrinsically long circulation times due to 
their composition. 
 Polymersomes can generally be prepared by two different methods, phase-
inversion, and polymer rehydration. The phase-inversion technique involves dissolving 
the diblock copolymer in an organic solvent, followed by hydration with aqueous solvent. 
Typically, this process yields fairly uniform nanovesicles that can be tuned through 
polymer concentration and organic-to-water ratio.
83
 This process results in self-assembly 
by increasing the interfacial tension between the hydrophobic polymer blocks and the 
hydration solution. The polymer rehydration method involves dissolving the diblock 
copolymer in organic solvent and forming a thin film by evaporation of the organic 
solvent. Self-assembly is promoted by hydration with water. With the polymer 
rehydration technique, vesicles are formed as the water permeates the polymer film 
through defects, causing the polymer to lift from the surface. Polymer rehydration 
typically yields larger vesicles that can be made smaller and more uniform through 
extrusion.
89
 
B. Light-activated polymersomes 
 Much attention has been dedicated to designing "smart" polymersomes, or 
polymersomes that respond to a stimulus to release cargo. This stimulus can be an 
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internal or external trigger such as degradation by hydrolysis, temperature, pH, magnetic 
fields, or light.
90
 This review will focus on examples of polymersomes that undergo 
membrane disruptions in response to light. Light-responsive polymersomes are an 
attractive method of controlled release because light can be easily externally manipulated 
for release of cargo with high spatial and temporal resolution.  
 One such system by Mabrouk et al. used an azobenzene group incorporated 
within the diblock copolymer to promote rapid membrane disruptions in response to UV 
light.
91
 Asymmetric micron-sized polymersomes were assembled through two block 
copolymers, an inert copolymer, polyethyleneglycol-polybutadiene  (PEG-b-PBD), and a 
liquid crystal based copolymer, PEG-b-PMAazo444 (PAzo). The liquid crystal block 
contained an azobenzene group which underwent a trans-to-cis configurational transition 
in response to UV light. The isomerization caused a conformational change in the block 
from a rod to a coil, which induced an area difference between the two polymer 
monolayers sufficient to trigger membrane rupture.  
 Another example of a light-responsive micron-sized polymersome system was 
presented by Robbins et al.
92
 This system was the first example of a photoactive 
polymersome formed by incorporating a protein in the aqueous interior and a meso-to-
meso ethyne-bridged bis[(porphinato)zinc] (PZn2) chromophore in the membrane. 
Micron-size vesicles were self-assembled using a polyethylene oxide-polybutadiene 
(PEO30-PBD46, denoted OB29) diblock copolymer. Two different proteins, horse spleen 
ferritin (HSF) or iron-free apoferritin (HSAF), were encapsulated within the aqueous 
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core. Incorporation of the PZn2 chromophore into the vesicle's hydrophobic membrane 
allowed for light absorption of near-UV to near-IR wavelengths. Irradiation with 488, 
543, and 633 nm induced irreversible membrane deformities ranging from "budding" to 
complete rupture. It was hypothesized that the protein associated with the inner 
membrane, causing asymmetrical membrane deformation upon PZn2 energy dissipation 
as heat, which ultimately resulted in membrane rupture. A small molecule, biocytin, was 
encapsulated within the core and 25-50% release was demonstrated upon light exposure. 
 The work by Robbins et al.
92
 was further explored by Kamat et al.
93
 and 
subsequently resulted in a general method for producing photoresponsive micron-sized 
vesicles with chromophore PZn2 in the hydrophobic membrane. Following up on the 
work by Robbins et al., it was hypothesized that any luminal solute that associates with 
the inner leaflet of the membrane can induce polymersome rupture when combined with 
PZn2 in the membrane. Dextran was investigated as a luminal encapsulant due to its 
biocompatibility and aqueous solubility. It was shown that inclusion of dextran could 
induce membrane instability upon irradiation. Studies were performed varying the size of 
the dextran and molecular weight of the polymer, and it was shown that 
photoresponsiveness increased with molecular weight and dextran concentration. 
Additional work by Kamat et al. explored this system for use as a membrane stress 
sensor.
94
 cIt was demonstrated that PZnn fluorophores underwent significant red emission 
shifts as a response to environmental crowding within a polymersome membrane. 
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 To date, only one example exists of a photoresponsive nanoscale polymersome. It 
is important to develop light-responsive vesicles on the nano-scale for biological 
applications, as micron vesicles are not sized appropriately for in vivo experiments. 
Mammalian cells, such as HeLa cells, are typically 10-20 µM in diameter, therefore it is 
necessary to develop much smaller carrier systems for these applications. Additionally, 
passive uptake of polymer-based nanoparticles by red blood cells has been shown to 
occur for particles less than 200 nm.
95
   
 Cabane et al. presented a photocleavable amphiphilic diblock copolymer, 
poly(methyl caprolactone)-ONB-poly(acrylic acid) (PMCL-ONB-PAA) that self-
assembled into micelles and 150 nm polymersomes.
96
 qcThis block copolymer contained 
an o-nitrobenzyl moiety as a photocleavable linker between the hydrophilic and 
hydrophobic polymer chains. UV-irradiation induced a successful cleavage of the diblock 
copolymer chains, both in THF and aqueous solution, as well as in self-assembled 
vesicles. This work was further extended to probe the ability of this system to encapsulate 
and release two small molecules, as well as a large biomolecule, green fluorescent 
protein.
97
 Irradiation with 365 nm light induced polymersome disintegration within 
minutes. Upon irradiation, cargo was released and polymersome morphology was shown 
by cryo-TEM to transition from vesicles to micelles. This nanoscale system provides a 
promising route to deliver cargo in vivo with UV light, and can be tuned for delivery 
needs by altering the number of photocleavable moieties in the polymer. 
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Figure 1-11. General schematic of a polymersome.  
The hydrophobic membrane, shown in gray, is composed of a hydrophobic polymer (black) and 
hydrophilic polymer (green). A common diblock copolymer used for polymer self assembly is 
PBDx-PEOy. The hydrophilic lumen for encapsulating cargo is shown in blue. 
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Figure 1-12. Cartoon of a PEG-b-PBD/PEG-b-PMAzo444 polymersome and response to UV 
light.  
Under  UV  illumination,  isomerization  of the azobenzene induces  a conformational  change of  
the  diblock copolymer, resulting in vesicle rupture.  
Figure adapted from E. Mabrouk. et. al. P.N.A.S. 2009, 106, 7294-7298 
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Figure 1-13. Nitrobenzyl-linked light-responsive polymersome.  
Chemical structure of the poly(methyl caprolactone)-ONB-poly(acrylic acid) diblock copolymer 
and degradation products upon UV irradiation are shown. 
Figure adapted from E. Cabane et. el. Soft Matter, 2011, 7, 9167–9176 
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V. Research Aims 
 Work presented in this thesis demonstrates three unique designs for biomolecular 
caging, all responsive to different wavelengths of light. The first two designs involve the 
site-specific incorporation of a caging moiety, and the third design involves encapsulation 
within a light-activated polymersome nanocarrier. Specifically, Chapter 2 presents a 
caged antagomir for the regulation of let-7 miRNA, in zebrafish embryos. This caged 
antagomir provides the ability to block the activity of a miRNA in vivo upon 
photoactivation with 365 nm light. Additionally, Chapter 2 presents a caged miRNA, 
providing a method of introducing an exogenous miRNA into zebrafish embryos and 
activating it upon irradiation. Used together, these two constructs provide the ability for 
bidirectional control of a miRNA. Chapter 3 focuses on the design, synthesis, and 
application of a ruthenium-based visible-light photolinker, RuBEP. Two antisense 
morpholinos were circularized with RuBEP through click-chemistry, and activated in 
zebrafish embryos with 450-nm light. Chapter 3 demonstrates an encapsulation-based 
approach for caging through the use of photo-responsive nano-polymersomes. These 
nano-polymersomes were used to encapsulate oligonucleotides, small molecules (FITC), 
and metal ions (Zn
2+
 and Ca
2+
) and cargo was released with 488 nm light.  
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Chapter 2 
 
Caged oligonucleotides for bidirectional photomodulation of let-7 in 
zebrafish embryos 
 
This chapter was adapted from J.C. Griepenburg et. al. Bioorg. Med. Chem. 2013, 21, 6198-6204. 
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I. Introduction 
 MicroRNA (miRNA) is a large class of non-coding RNA that interferes with post-
transcriptional gene expression through binding to the 3′ UTR of mRNA. Since the 
discovery of the first miRNA in 1993, lin-4, it has been found that miRNAs are abundant 
short RNAs that have important roles in normal developmental and cellular processes, as 
well as in human disease.
1,2
 
 Unlike short interfering RNA (siRNA), a single miRNA can interfere with 
multiple gene targets, as binding does not require perfect complementarity except in the 
5′ seed region.3,4 This makes elucidation of miRNA function particularly challenging as a 
single miRNA can have multiple roles that vary with cellular location and timing.
5
 Loss-
of-function miRNA studies are useful in determining miRNA pathways,
6
 but fall short in 
identifying multiple miRNA functions with spatial and temporal resolution. 
 Loss-of-function studies of miRNA are most commonly performed using anti-
miRNA oligonucleotides, also known as antagomirs.
7
 These oligonucleotides are 
perfectly complementary to the biologically active sequence of the miRNA and sterically 
block function by outcompeting the target mRNA. Various oligonucleotide backbone and 
ribose modifications have been previously studied to improve the efficacy of antagomirs, 
such as phosphorothioation, 2′-F RNA, 2′-OMe RNA, locked nucleic acid (LNA), as well 
as morpholinos which are commonly used in antisense applications.
4
 Reverse 
complementary 2′-OMe RNA can block miRNA function in C. elegans, based on 
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nuclease resistance and increased binding affinity as shown by melting temperature (Tm) 
studies.
6,8
 
 The complexity of gene expression patterns established in metazoan early 
development has motivated the creation of biochemical tools for controlling genes with 
higher spatial and temporal resolution.
9-12
 Light-activated approaches show considerable 
promise as near-UV/Vis/near-IR light of desired wavelength can be applied dose-
dependently and in a spatially and temporally controlled manner. In recent years, there 
have been advances in caging siRNA, allowing for spatial and temporal control of the 
RNA interference (RNAi) pathway. In 2005 the Friedman lab first reported caged siRNA 
by labeling the phosphate backbone of a siRNA duplex with 1-(4,5-dimethoxy-2-
nitrophenyl)ethyl moieties, which blocked the siRNA-RISC interaction before 
photolysis.
13
 Additional work by the Friedman lab blocked siRNA activity with a larger 
photocleavable cyclo-dodecyl (dimethoxy-2-nitrophenyl)ethyl moiety.
14
 The addition of 
steric bulk to the terminal phosphates prevents Dicer and nucleases that could remove the 
caging group, from interacting with the siRNA. Most recently, Kala et. al. presented a 
method of photoregulating siRNA with a tetra-DMNPE–modified duplex RNA, where 
the terminal phosphates are caged with regiospecific DMNPE.
15
  The terminal DMNPE 
groups effectively cage native siRNA until irradiated with 365 nm light. 
 While these and other
16,17
 advances have been made towards spatiotemporal 
control of the RNAi pathway, there has been much less reported for the biochemical 
modulation of miRNA. Recently, Zheng et al. reported a novel photoactivatable 
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antagomir for controlling miRNA in C. elegans.
18
 In this work, a caged hairpin-like 
structure was created by attaching a complementary blocking strand to the antagomir via 
a coumarin moiety. After irradiation, dissociation of the antagomir became more 
favorable, allowing binding to a miRNA target.
18
 Additionally, Connelly et al. reported a 
method of photomodulating miRNA in cells by attaching caging groups on specific bases 
of the miR-122 and miR-21 antagomirs.
19
 Here, we expand upon the caged hairpin 
antagomir. Moreover, we provide the first example of a caged miRNA, which makes it 
possible to “turn on” exogenously supplied miRNA via photoactivation. 
 Let-7, the miRNA of interest in this study, was discovered in 2000 in C. elegans 
by Reinhart et al. and was shown to play an important role in developmental timing.
20
 
Interestingly, this particular miRNA is evolutionarily conserved across humans, flies, 
mice, and zebrafish.
21
  Let-7 miRNA was chosen for the current investigation due to the 
developmental arrest caused by overexpression in Danio rerio (zebrafish) embryos, 
resulting in a readily observable phenotype.
5
 This phenotype is characterized by reduced 
head and eye formation, shortened tail, and limited yolk sack extension.
5
 Let-7 miRNA is 
not endogenously expressed in zebrafish embryos until 48 hours post fertilization (hpf), 
but an early let-7 expression phenotype can be induced by injecting the let-7 miRNA at 
the one-cell stage. This phenotype is clearly visible at 24 hpf.
5
 Representative examples 
of zebrafish embryos showing the let-7 early induction phenotype are shown in Figure 2-
1. This provides a miRNA-vertebrate model system to photoregulate miRNA in both 
directions--from "off to on" and "on to off".  
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 Novel oligonucleotide constructs were developed for regulating miRNA in 
zebrafish embryos: two caged hairpin antagomirs (CHANT1, CHANT2) for blocking 
miRNA function with 365 nm light, as well as a caged circular miRNA (CIRClet7) for 
introducing exogenous miRNA into a system with 365 nm light. The design of CHANT1 
was guided by our lab’s experience in developing caged hairpins with a single 
photocleavable linker for photoactivating antisense oligonucleotides in zebrafish 
embryos.
22
 This is similar to the caged hairpin antagomir recently published by Zheng et 
al.
18
 In CHANT2, we expand upon this design by incorporating a longer blocking sense 
strand and second photocleavable linker. Finally, the circular miRNA expands on our 
previous circular design involving the 10-23 DNAzyme,
23
 and also draws inspiration 
from several notable circular caged oligonucleotide constructs that have recently been 
published.
24-26
   
 
II. Experimental procedures 
 
A. Synthesis, purification, and characterization of light-activated miRNA 
antagomirs: CHANT1 and CHANT2 
 CHANT1 and CHANT2 were synthesized on a 1 µmol scale using published 
methods for oligonucleotide synthesis on solid support using an ABI 394 DNA 
synthesizer.
27,28
 CHANT1 and CHANT2 were cleaved from solid support using 
concentrated ammonium hydroxide for 16 h, and HPLC purified (Figure 2-2). A reverse-
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phase C18 semi-preparatory column was used on an Agilent 1100 HPLC system. A 
gradient of 10% - 80% acetonitrile in 0.05 M triethylammonium acetate (TEAA) was 
used for purification of all oligonucleotides containing a dimethoxytrityl (DMT) 
protecting group (Table 2-1). The DMT protecting group was removed using 80% glacial 
acetic acid for 20 min at rt. A NAP-5 column was used for buffer exchange after 
purification and deprotection. After HPLC purification, approximately 100 nmol of pure 
material was isolated. 
 
Table 2-1. Gradient for HPLC purification of CHANT1 or CHANT2 after cleavage from 
solid support.  
A gradient of 0.05 M triethylammonium acetate in H2O was used with a Zorbax reverse-phase 
C18 column. The column was heated to 40 °C during purification.  
 
 
 
 
 
 
B. Synthesis and purification of CIRClet7 
 CIRClet7 was synthesized on a 1 µmol scale using published methods for 
oligonucleotide synthesis on solid support using an ABI 394 DNA synthesizer.
29
 A 
FMOC-protected amino solid support was used on the 3′ end and a disulfide 
Time (min) % Acetonitrile % 0.05 M TEAA 
0.0 90 10 
40.0 40 60 
50.0 20 80 
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phosphoramidite was incorporated at the 5′ end. The construct was cleaved from solid 
support using concentrated ammonium hydroxide for 16 h, and HPLC purified (Figure 2-
2A). A reverse-phase C18 column was used on an Agilent 1100 HPLC system. A 
gradient of 10% - 80% acetonitrile in 0.05 M triethylammonium acetate (TEAA) was 
used for purification of all oligonucleotides containing a dimethoxytrityl (DMT) 
protecting group (Table 2-2B). The DMT protecting group was removed using 80% 
glacial acetic acid for 20 min at rt. A NAP-5 column was used for buffer exchange and 
desalting after purification and deprotection. After HPLC purification, approximately 30 
nmol of pure material was attained. 
 The 3′ amine was reacted with an excess of sulfo-EMCS linker. A 0.4 mg/mL 
linker solution was prepared in 0.1 M PBS buffer, pH 7.2. The reaction was allowed to 
proceed for 30 min at 37 °C and quenched by removing excess sulfo-EMCS with a NAP-
5 column. The 5′ disulfide was then reduced with TCEP at 37 °C, and the circularization 
reaction with 5′ thiol was allowed to proceed for 24 h. Circularization was confirmed by 
visualizing bands by gel electrophoresis. Circularization yield was determined by band 
quantification using ImageQuant TL 7.0 Image Analysis Software with the rubber band 
background subtraction method. Circular product was purified from linear starting 
material using anion exchange HPLC (Figure 2-3B). A Dionex DNAPac PA100 anion 
exchange column was used with a gradient of NaClO4 in the presence of Tris-Cl pH 8.0 
to separate linear starting material from circularized product (Table 2-2B). 
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Table 2-2. Gradients for HPLC purification of CIRClet7 A) after solid-phase synthesis and 
B) after circularization.  
A)  Zorbax C18 column heated to 40 °C during purification  B) DNAPac PA100 column heated 
to 60 °C during purification.  
 
A) 
 
 
 
 
 
B) 
 
 
C. Characterization 
 Melting temperature analysis was performed on a Beckman Coulter DU800 
spectrophotometer with a Peltier temperature controller and Tm analysis software. A 
solution of 1 µM oligonucleotide in 50 mM NaCl in deionized H2O was used for all 
Time (min) % Acetonitrile % 0.05 M TEAA 
0.0 90 10 
40.0 40 60 
50.0 20 80 
Time (min) % H2O % 0.25 M Tris-Cl pH 8 % 0.375 M NaClO4 
0.0 88 10 2 
0.1 58 10 32 
26.1 32 10 58 
26.5 0 0 100 
34.5 0 0 100 
35.0 88 10 2 
50.0 88 10 2 
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melting temperature experiments. Samples were irradiated using a Spectroline TR-365R 
transilluminator delivering 9 mW/cm
2
 centered at 365 nm for 10 min. Melting 
temperatures were analyzed by varying the temperature between 15 °C and 90 °C at a 
rate of 1 °C per min, in both forward and reverse directions. 
 Gel electrophoresis was performed using a 20% polyacrylamide gel containing 7 
M urea. Gels were run at 300 V for 45 min and stained with ethidium bromide. Gels were 
imaged with a GE Typhoon FLA 7000 imager. Masses were confirmed by the Wistar 
Proteomics Facility using an Applied Biosystems Voyager 6030 with 3-hydroxypicolinic 
acid (3-HPA) as matrix (Table 2-3, Figure 2-4). 
  
Table 2-3. Masses determined for CHANT1 and CHANT2 by MALDI-TOF MS. 
 
 
 
 
 
D. In vivo studies 
 Zebrafish embryos were obtained from CDB Zebrafish Core Facility at the 
University of Pennsylvania. Both Tu and TLF wildtype embryos were used for these 
studies. Zebrafish embryo injection solutions were prepared to contain a final 
concentration of 0.1 M KCl and 0.25% phenol red dye. All injections were performed at 
the one-cell stage and injected into the cell compartment only. A Harvard Apparatus PLI-
 Expected Mass 
(m/z) 
MALDI Mass 
(m/z) 
CHANT1 11,683 11,466 
CHANT2 14,336 14,498 
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100 pico-injector was used to inject controlled volumes. Injection volume was calibrated 
to dispense 8 - 10 nL per embryo. Zebrafish embryos were incubated at 28 °C in E3 
zebrafish medium.
30
 All embryos were incubated in the dark, except for irradiated 
samples which were exposed to near-UV light for the stated time and returned to the dark 
incubator. Embryo micrographs were collected at 24 hpf with an Olympus FV1000 laser 
scanning confocal microscope using transmitted light imaging. A 10x air objective was 
used for single embryo imaging. 
 
E. Materials 
 2′-OMe RNA phosphoramidites for solid-phase oligonucleotide synthesis and all 
modified phosphoramidites, including CPG solid supports, were purchased from Glen 
Research (Sterling, VA). Product numbers for photocleavable spacer phosphoramidite, 
amino modifier CPG, and thiol modifier phosphoramidite are 10-4913-90, 20-2957-01, 
10-1926-90, respectively. N-Ɛ-Maleimidocaproyl-oxysulfosuccinimide ester (Sulfo-
EMCS) linker was purchased from Thermo Scientific (Pierce Protein Biology Products). 
NAP-5/10 desalting columns were purchased from GE Healthcare. Let-7 miRNA (5′-
UGAGGUAGUAGGUUGUAUAGUU-3′) was ordered from Integrated DNA 
Technologies (IDT). 
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Figure 2-1. let-7 early induction phenotype.  
Zebrafish embryos injected at the 1-cell stage with 10 M let-7 miRNA show the let-7 early 
induction phenotype when imaged at 24 and 50 hpf (right images), compared to un-injected 
wildtype (Tu x Tu) embryos (left images). The early induction let-7 miRNA phenotype is 
characterized by decreased head formation, shortened tail, and yolk that fails to extend along the 
tail. 
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Figure 2-2. HPLC trace for CHANT1.  
Purification of CHANT1 after cleavage from solid support was performed using a Zorbax C18 
column with a gradient of 0.05 M triethylammonium acetate in H2O. Column was heated to 40 °C 
during purification. Product eluted at 30 - 31 min with gradient in Table 2-1. 
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A 
 
 
 
B 
 
 
Figure 2-3. HPLC traces for purification of CIRClet7.  
A) Purification of linear oligonucleotide after cleavage from solid support was performed using a 
Zorbax C18 column with a gradient of 0.05 M triethylammonium acetate in H2O. Column was 
heated to 40 °C during purification. Retention time of product was 46 min. B) Purification of 
circular product after circularization procedure using a DNAPac PA100 column with a gradient 
of 0.25 M Tris-Cl pH 8 and 0.375 M NaClO4 in H2O (adapted from manufacturer protocol). 
Column was heated to 60 °C during purification. Retention time of CIRClet7 was 34 min. 
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Figure 2-4. Masses determined for A) CHANT1 and B) CHANT2 by MALDI-TOF MS.  
MALDI-MS was performed by the Wistar Proteomics Facility at the University of Pennsylvania. 
All masses were attained in linear negative mode, using 3-hydroxypicolinic acid (3-HPA) matrix. 
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III. Results and discussion 
 
A. Photoactivatible miRNA antagomir: CHANT1 
 A caged hairpin antagomir (CHANT1) was designed and synthesized to “turn off” 
let-7 miRNA with a low dose of 365 nm irradiation. This antagomir consisted of a 22-
mer oligonucleotide synthesized with all 2′-OMe RNA bases (Figure 2-5). The function 
of this antagomir was inhibited by a shorter 12-mer 2′-OMe RNA blocking strand. The 
antagomir and blocking strand were covalently attached by a nitrobenzyl photocleavable 
linker, PL (shown in red). Prior to photolysis, PL stabilized the hairpin hybrid form, 
thereby blocking the function of the antagomir. Upon near-UV irradiation, PL was 
cleaved, resulting in a destabilized hybrid. The photoactivated 22-mer 2′-OMe RNA 
antagomir can readily hybridize to the complementary miRNA and sterically block its 
function. 
 In designing CHANT1, a balance was struck between antagomir blocking 
efficiency and restoration of antagomir function post-irradiation. In principle, all 
antagomir nucleotides can be sterically blocked with a 22-mer blocking sequence; 
however, this would disfavor dissociation post-irradiation. For this particular construct, a 
12-mer blocking strand was chosen to block the antagomir at the 5' seed region, as this 6-
8 nucleotide sequence has been shown to be important in miRNA-mRNA target 
recognition.
31,32
 Additionally, terminating the blocking sequence with a guanine or 
cytosine base should result in a more stable hybrid due to the increase in hydrogen 
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bonding. For this reason, the placement and length of the blocking strand for this 
particular sequence was chosen to be a 12-mer as shown in Figure 2-5.  
 CHANT1 was synthesized by solid-phase synthesis, isolated by HPLC 
purification (Figure 2-2, Table 2-1)), and confirmed by MALDI-TOF MS to have the 
correct mass (Figure 2-4, Table 2-3). Melting temperature analysis has proved to be a 
useful tool to determine nearly the optimal length of the blocking strand. Melting 
temperature analysis showed a CHANT1 melting temperature of   85 °C, indicating 
favorable duplex stability. The Tm dropped to 64 °C post-photolysis, decreasing the 
melting temperature (∆Tm) by at least 21 °C (Figure 2-6). This ∆Tm indicates significant 
photomodulation of duplex stability and is comparable to many caged hairpins 
synthesized in our laboratory.
33-35
 However, the post-photolysis Tm of 64 °C suggests that 
a significant amount of antagomir remains bound to the blocking strand (and therefore 
inactive), even after uncaging.  
 To confirm the efficacy of the exogenous let-7 miRNA in vivo, a 10 µM solution 
was injected into zebrafish embryos at the one-cell stage (n = 35). Injection resulted in 
the let-7 miRNA early induction phenotype in 92% of embryos (Figure 2-1). In vivo 
studies with CHANT1 were subsequently performed by co-injecting a 10 µM solution of 
let-7 miRNA, together with varying concentrations (40 - 100 µM) of CHANT1 into 
embryos at the one cell stage. CHANT1 at 50 µM exhibited high activity with minimal 
toxicity. Thus, a 10 µM solution of let-7 miRNA and 50 µM CHANT1 was subsequently 
injected into all zebrafish embryos at the one-cell stage. Half of the injected embryos 
 61 
 
were allowed to incubate at 28 °C in the dark, while the other half were irradiated at 1 
hpf. A near-UV transilluminator was used to irradiate the embryos for 10 min in E3 
zebrafish media. The embryos were incubated for 24 h at 28 °C, and then imaged to 
determine phenotypic response. Of the embryos that were irradiated with 365 nm light (n 
= 21), the majority (86%) developed normally, indicating that the caged antagomir was 
photoactivated and able to block let-7 miRNA function (Figure 2-7). In the non-irradiated 
embryo group (n = 15), the majority (80%) developed with the let-7 miRNA early 
induction phenotype, as expected. However, a significant minority (20%) of the embryos 
developed normally (Figure 2-10), indicating incomplete caging of CHANT1. Although 
this caged hairpin exhibited a very high Tm, only 12 of the 22 antagomir nucleotides were 
blocked from let-7 miRNA binding.  
 
B. Photoactivatible miRNA antagomir: CHANT2 
 A second caged hairpin antagomir, CHANT2 (Figure 2-5B), was developed with 
the goal of minimizing background miRNA binding pre-photolysis, while maximizing 
miRNA binding post-photolysis. To achieve these aims, we reasoned that the caged 
hairpin must form a longer, stable duplex structure prior to irradiation, and become less 
thermodynamically stable afterwards. In particular, the high melting temperature of 
CHANT1 post-photolysis indicated a route to further optimization. 
 To minimize caged antagomir background activity, the number of complementary 
bases in the blocking sequence was increased such that fewer antagomir bases were 
available to bind to the miRNA. By adding an additional photocleavable moiety in the 
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blocking strand, it was possible to incorporate more bases within the blocking strand, 
without sacrificing antagomir activity after irradiation. Prior to in vivo studies, one goal 
in design optimization was to increase ∆Tm, pre- vs. post-photolysis.  
 The same 22-mer antagomir complementary to let-7 miRNA was covalently 
attached via a PL to a blocking strand comprised of a 9-mer and 10-mer linked by an 
additional PL (Figure 2-5B). This PL blocking strand design was guided by our 
previously published RNA “bandage" which used two shorter sequences linked by a PL 
to achieve mRNA blocking pre-photolysis and dissociation post-photolysis.
36
 Consistent 
with successful RNA bandage designs,
36
 a one nucleotide gap was introduced at the 
position of the PL. Finally, because terminating the blocking sequence with a guanine or 
cytosine base should result in a more stable duplex, the blocking strand was extended by 
one base on the 3′ end to a 10-mer to facilitate G/C base-pair termination.  
 CHANT2 was synthesized on solid support, purified by HPLC (Figure 2-2, Table 
2-1) and the mass was confirmed by MALDI-TOF MS (Table 2-3, Figure 2-4). The ∆Tm 
for CHANT2 was measured to be -38 °C: Tm (-UV) = 71 °C, Tm (+UV) = 33 °C (Figure 2-8). 
Significantly, Tm (+UV) was much closer to rt than observed for CHANT1, which should 
improve the miRNA-binding activity of the uncaged antagomir. Moreover, relative to 
CHANT1 with a single 12-mer blocking strand, CHANT2 exhibited a significantly 
greater difference in thermal stability pre- vs. post-photolysis, ∆∆Tm = 17 °C. 
Interestingly, Tm (-UV) was significantly lower for CHANT2 than CHANT1, which 
indicates that the 9-mer-PL-10-mer blocking strand did not behave as a contiguous 19-
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mer. This is likely due to the intervening PL, and also the one nucleotide gap included in 
the 9-mer-PL-10-mer design. This is further corroborated by the appearance of the broad 
Tm curve. Upon photolysis, two short oligonucleotides of different lengths will dissociate 
at different temperatures, causing the melting curve to broaden.  
 Based on Tm alone, it would appear as though CHANT1 would be more stable 
prior to photolysis due to a higher melting temperature. However, when the structure of 
CHANT2 is taken into account and analyzed together with in vivo data, it is clear that 
thermal stability alone is not a clear predictor of blocking efficiency. In cases where the 
Tm is significantly above incubation temperature, it is expected that the hairpin will 
remain annealed. A more important factor becomes the antagomir bases that are sterically 
blocked when the caged hairpin is fully annealed, and this is why the addition of the 
second PL becomes so critical for in vivo efficiency. Preliminary in vivo studies were 
performed by co-injecting a 10 µM solution of let-7 miRNA with varying concentrations 
(30 – 100 µM) of CHANT2 into embryos at the 1-cell stage. CHANT2 at 50 µM 
exhibited high activity with minimal toxicity. Thus, a 10 µM solution of let-7 miRNA 
and 50 µM CHANT2 was subsequently injected into all zebrafish embryos at the one-cell 
stage. Half of the injected embryos were incubated at 28 °C in the dark, while the other 
half were irradiated at 1 hpf for 10 min with the near-UV transilluminator. The embryos 
were incubated for 24 h in the dark at 28 °C and then imaged to determine phenotypic 
response (Figure 2-9). The embryos that were irradiated (n = 40) developed normally 
which clearly showed that the uncaged antagomir was active. Photoactivated CHANT2 
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rescued the normal wildtype phenotype for nearly 90% of zebrafish embryos, vs. 80% for 
CHANT1 embryos (Figure 2-10). A marked improvement was also seen in antagomir 
caging in the non-irradiated embryos (n = 45), with just 2% background activity for 
CHANT2 compared to 20% for CHANT1 (Figure 2-10). This 2% background can be 
attributed to injection error, which can range from 0 - 10% of embryos. This construct 
was also tested at lower concentrations (30 - 50 µM) and it was demonstrated that in vivo 
efficiency is dependent on concentration. This concentration dependence is expected, as 
the amount of free antagomir post-photolysis directly depends on the incubation 
temperature (28°C) which happens to be below the Tm. The concentration reported with 
maximum efficiency is far below 100 µM, the concentration where significant toxicity 
was observed. 
 The significant decrease in CHANT2 background activity as compared to 
CHANT1 highlights that the 9-mer-PL-10-mer blocking strand caged the antagomir more 
effectively than the original 12-mer, despite the lower thermal stability of CHANT2 (Tm 
= 72 °C) relative to CHANT1 (Tm   85 °C) (Figure 2-6, 2-8). The melting temperature 
for CHANT1 is reported as   85 °C as the exact temperature cannot be determined since 
a full transition cannot be observed at such a high Tm. The data indicate that CHANT2 is 
nearly optimized for photomodulating the let-7 antagomir in the current experimental 
paradigm, where miRNA is co-injected in zebrafish embryos. 
 With the creation of CHANT1 and CHANT2 and the two previously published 
caged antagomirs,
19,37
 a new class of tools for downregulating miRNA with light is 
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emerging. Connelly et al. presented an elegant method of caging antagomirs miR-122 and 
miR-21 with minimal background activity and showed efficient antagomir restoration 
post-photolysis, however, this involved the use of custom caged bases. Zheng et al. 
presented the first example of in vivo miRNA photomodulation by using a caged hairpin 
antagomir. To achieve very efficient caging and uncaging, it was necessary to design and 
test a large number of caged antagomirs. Our CHANT2 design minimizes the need for 
optimization, as the second PL allows a much larger portion of the antagomir to be 
blocked without sacrificing uncaging efficiency. This will facilitate the targeting of 
multiple miRNAs without optimization necessary for each sequence. Additionally, the 
commercial availability of the 2′-OMe RNA phosphoramidites and PL used in CHANT2 
make it readily accessible to biological researchers. 
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Figure 2-5. Structures of caged hairpin antagomirs CHANT1 and CHANT2.  
A) CHANT1: A 22-mer miRNA antagomir targeting let-7 miRNA was covalently attached to a 
complementary 12-mer blocking sequence via a nitrobenzyl photocleavable linker, PL (in red). 
Upon photolysis, the 12-mer more readily dissociated, restoring antagomir function. B) 
CHANT2: A 22-mer miRNA antagomir targeting let-7 miRNA was covalently attached to a 5′-9-
mer-PL-10-mer blocking sequence. Upon PL photolysis, antagomir function was restored. All 
sequences consisted of 2′-OMe RNA bases. 
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Figure 2-6. Melting temperature data for CHANT 1. 
Melting temperature analysis of CHANT1 showing a Tm of   85 °C prior to photolysis, and 64 
°C post-photolysis, decreasing the melting temperature (∆Tm) by at least 21 °C 
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Figure 2-7. CHANT1 in vivo experiments.  
A) Embryos injected at the 1-cell stage with 10 M let-7 miRNA showed let-7 early induction 
phenotype. B) Embryos injected with 10 µM let-7 miRNA + 50 µM CHANT1 showed similar 
let-7 early induction phenotype prior to 365 nm irradiation. C) Embryos injected with 10 µM let-
7 miRNA + 50 µM CHANT1 developed normally after 365 nm irradiation for 10 min at 1 hpf. 
All embryos were imaged at 24 hpf. 
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Figure 2-8. Melting temperature data for CHANT2 
Melting temperature analysis of CHANT1 showing a Tm of    °C prior to photolysis, and 33 °C 
post-photolysis, decreasing the melting temperature (∆Tm) by  38 °C. 
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Figure 2-9. CHANT2 in vivo experiments.  
A) Embryos injected at the 1-cell stage with 10 M let-7 miRNA showed let-7 early induction 
phenotype. B) Embryos injected with 10 µM let-7 miRNA + 50 µM CHANT2 antagomir showed 
let-7 early induction phenotype prior to 365 nm irradiation. C) Embryos injected with 10 µM let-
7 miRNA + 50 µM CHANT2 developed normally after 365 nm irradiation for 10 min at 1 hpf. 
All embryos were imaged at 24 hpf. 
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Figure 2-10. CHANT1 vs. CHANT2 in vivo efficiency. 
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C. Caged circular miRNA, CIRClet7  
 In addition to the caged hairpin antagomirs, which provide a method to “turn off” 
miRNA with light, caged circular let-7 miRNA (CIRClet7) was designed to “turn on” 
exogenous miRNA with light. The circular design provides a way to introduce miRNA 
into a biological system and subsequently activate at the desired place and time by 
irradiating with 365 nm light.  
 Similar to the caged antagomirs, this caged miRNA uses fully 2′-O-methylated 
bases to limit degradation that is problematic with unmodified RNA. A complementary 
22-mer 2′-OMe RNA miRNA and blocking strand were synthesized containing two PLs, 
a free amine on the 3′ end, and a disulfide on the 5′ end as shown in Figure 2-11. The 5′ 
and 3′ ends were linked together in a "circularization reaction" by first reacting the 
succinimide of a commercially available heterobifunctional linker with the 3′-amine. The 
5′-disulfide was then reduced with TCEP, allowing subsequent reaction with the linker 
maleimide and resulting in a circularized oligonucleotide. Both the linear and circularized 
oligonucleotides were purified by HPLC (Figure 2-3, Table 2-2). Upon photolysis, the 
circular miRNA was linearized as shown in Figure 2-11. The phosphate group revealed 
on the 5' end of the biologically active miRNA allows for processing by the multi-protein 
RNA-induced silencing complex (RISC). Our lab’s previous circular design for caged 
DNAzymes used Circligase for circularization, which limited the reaction to the picomole 
scale.
38
 By using the heterobifunctional linker, more oligonucleotide can be circularized 
in a single reaction. Circularization yield, calculated from gel band intensity, was 
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determined to be 45% when performed on a 1 nmol scale (Figure 2-12). Additionally, a 
method was developed to purify the circular construct by HPLC without having to do 
lengthy gel extractions to remove linear starting material. Purity was confirmed by a 
well-resolved product peak on HPLC which was further analyzed using gel 
electrophoresis (Figures 2-3B, 2-12).  
 To test this circular miRNA in vivo, a 20 µM solution of CIRClet7 was injected 
into zebrafish embryos at the one-cell stage. Half of the injected population was 
incubated in the dark at 28 °C (n = 18). The other half was irradiated with 365 nm light 
for 10 min at 1 hpf before incubation (n = 21). The embryos were analyzed and imaged at 
24 hpf for phenotypic response. As shown in Figure 2-13, embryos injected with the 
caged miRNA developed normally, while embryos injected and irradiated developed with 
the let-7 miRNA early induction phenotype. These results were seen in 100% of embryos 
injected, indicating that there was no background activity prior to photolysis and 
uncaging completely restored miRNA activity. Interestingly, the phenotype induced by 
the 2′-OMe RNA circular design varies slightly from the phenotype induced by the let-7 
miRNA. A 2′-OMe RNA control miRNA was injected into zebrafish embryos (Figure 2-
14) to confirm that this was not a result of the circular construct, but rather a result of an 
analog used to induce the miRNA phenotype. 
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Figure 2-11. Synthesis and photocleavage of circular caged miRNA (CIRClet7)  
A photocleavable oligonucleotide duplex with 3′-amine and 5′-thiol was circularized with a 
heterobifunctional crosslinker. The crosslinker was first reacted with the 3′-amine, and 
circularization proceeded after 5′ disulfide reduction with TCEP. Upon photolysis, the active 
miRNA strand was released with a 5′-phosphate for processing by RISC. 
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Figure 2-12. Gel electrophoresis of CIRClet7 crude reaction mixture and CIRClet7 after 
HPLC purification.  
A) Gel after CIRClet7 circularization procedure used to calculate circularization yield by band 
intensity. ImageQuant TL 7.0 was used for band quantification using the rubber band subtraction 
method. Circularization yield was calculated to be 45%. B) Gel after HPLC purification of 
CIRClet7 showing only circularized product. All gels were cast using 20% polyacrylamide and 7 
M urea and run at 300 V for 45 min. Gels were stained with ethidium bromide. 
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Figure 2-13. CIRClet7 in vivo experiments.  
A) Zebrafish embryos injected with 20 µM CIRClet7 and incubated in the dark developed 
normally. B) Embryos irradiated with 365 nm light developed with the early induction let-7 
miRNA phenotype. All embryos were imaged at 24 hpf. 
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Figure 2-14. Comparison of control, RNA-induced phenotype, and 2′-OMe RNA-induced 
phenotype.  
A)  Uninjected control embryo imaged at 24 hpf showing normal development. B) Embryo 
injected with 15 µM let-7 2′-OMe RNA showing a variation of the let-7 early induction 
phenotype. C) Embryo injected with 10 µM let-7 RNA showing a variation of the let-7 early 
induction phenotype. 
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IV. Conclusion 
 miRNAs are an abundant class of small gene-regulating RNAs, and our 
understanding of their diverse biological functions is still incomplete. New chemical 
tools, such as those introduced here, will make it possible to probe how each miRNA 
regulates a multitude of genes in different locations and at different times in vivo. 
 A set of caged antagomir and caged miRNA constructs have been designed with 
the ability to regulate miRNA from "on to off" as well as "off to on" with light. These 
tools were shown to control exogenously supplied miRNA and have the potential to 
control endogenous miRNA as well. These caged constructs are effective in zebrafish 
embryos and could readily be optimized for use in other model organisms, such as 
Xenopus
39
 and C. elegans.
6,8
 By using 2′-OMe RNA oligonucleotides, the synthesis of 
these constructs was greatly simplified, as these analogs can be prepared very 
successfully on solid support using commercially available phosphoramidites.  
 Two caged antagomir designs were designed, CHANT1 and CHANT2. With the 
addition of the second photocleavable linker in CHANT2, more antagomir bases were 
sterically blocked prior to irradiation without sacrificing antagomir activity post-
photolysis. With the addition of a second PL, the blocking strand could be lengthened to 
diminish background activity seen in the first design. Previously, our lab described 
several examples of caged antisense hairpins with a similar design to CHANT1 using 
only one PL.
22,35
 Based on this current study, it appears beneficial to incorporate a second 
PL in many caged hairpin constructs. 
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 To introduce an exogenous miRNA and provide a method for turning a miRNA 
from "off to on", a circular caged miRNA was designed. CIRClet7 is the first example of 
a caged miRNA, and was demonstrated in a zebrafish model system. As not all 
developmental programs stem from the downregulation of a miRNA, it is also useful to 
have a tool to probe the effects of miRNA upregulation in different systems. The tools 
described herein will provide new ways to probe miRNA function, which until now has 
been difficult to resolve with loss-of-function experiments. A direct follow-up to this 
work could be the use of light-activatible probes to determine more precisely the genes 
on which let-7 miRNA acts in different locations and times in early embryo development, 
as it is known that there are multiple targets.
5
 While these constructs have been 
developed specifically for let-7 miRNA in zebrafish, these methods can very easily be 
applied to additional miRNAs in various biological systems. 
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I. Introduction 
 Photochemical methods for regulating the structure, function, and/or localization 
of molecular species provide a powerful toolkit for manipulating advanced materials as 
well as complex biological systems. For example, channelrhodopsin—a single 
component, light-activated cation channel protein from algae—was co-opted in the 
development of pioneering optogenetic approaches for manipulating the activity of 
specific neurons and controlling animal behavior.
1
 More generally, “caged” molecules,2 
whose latent biological activity can be revealed with light, have been widely adopted, 
particularly for the study of amino acids,
3
 peptides,
4
 neurotransmitters,
5
 and metal ions.
6
 
In each case, photoactivation with high spatiotemporal control can be achieved using a 
focused laser beam of suitable wavelength. Less investigated are caged oligonucleotides, 
despite the central roles played by DNA and RNA in Biology, and the tantalizing 
potential for being able to turn genes “on” or “off” with light. Synthetic challenges of 
site-specifically incorporating one or more photolabile moieties within a large 
oligonucleotide, and limitations arising from the available near-UV-activatible caging 
moieties, have slowed the development of such oligos.  
 A particular focus for caged oligo development has been antisense morpholinos, 
which are commonly used to block mRNA translation and modify pre-mRNA splicing in 
a variety of model organisms, including mouse, zebrafish, frog, sea urchin, and chick.
7
  
Morpholino antisense oligos are also being investigated for therapeutic applications in 
humans. Robust methods for photoregulating MO antisense knockdown should enable 
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the study of multiple, in vivo gene functions at specific locations and times, while also 
reducing the potential for systemic toxicity.  
  Initial caged antisense oligos from our lab
8-10
 and the Chen lab
11-13
 employed 
DNA hairpin-like designs with the antisense oligo conjugated to a shorter, 
complementary sense strand via a photocleavable linker. Deiters et al. subsequently 
presented caged morpholinos where multiple photocaged nucleotide monomers were 
incorporated during solid-phase synthesis.
14
 In this example, morpholino-mRNA 
hybridization was sterically blocked until the caging groups were released from the 
nucleobases.
14
 A newer design strategy, presented by Yamazoe et al.,
15
 Wang et al.,
16
 and 
Wu et al.,
17
 has involved "circularizing" the oligonucleotide, by attaching the 5′ and 3′ 
ends with a photocleavable linker. The covalent linkage enforces the closed circular 
conformation, which prevents efficient MO hybridization to target mRNA; photocleavage 
restores the linear, biologically active MO. All of these approaches have employed a 
photocleavable linker, such as o-nitrobenzyl or hydroxycoumarin, which yields optimally 
to near-UV irradiation.
18
 
 To expand in vivo applications using caged oligos, there is need for synthetically 
versatile photolinkers that can be activated at visible or near-IR wavelengths as near-UV 
light has poor tissue penetration and can be toxic at high exposure levels.
19-21
  Previous 
strategies include the use of near-IR-to-UV upconversion nanoparticles to achieve siRNA 
photoactivation in cells and tissues,
20
 however, this approach limits the potential for 
multiplexing experiments involving two (or more) orthogonally caged compounds. 
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Recently, Yamazoe et al. presented a 465 nm activatable coumarin derivative for MO 
caging.
22
 Here, we exploit versatile ruthenium photochemistry to achieve caged oligos 
that are efficiently activated with visible light.  
 Ruthenium complexes of the general type [Ru(bipyridine)2(X)2]
2+
, where X = 
amine,
23
 nitrile,
24
 pyridine,
25
 or thioether
26
 ligands, have been shown to undergo facile 
ligand exchange with solvent upon irradiation with visible one-photon or near-IR two-
photon excitation.
1,27
  Biologically active small molecules can be directly ligated to the 
Ru
2+
 center, and then released with visible light.
27
  In 2003 Etchenique and coworkers 
first applied this Ru-ligand exchange property by caging a potassium channel blocker, 4-
aminopyridine,
25
 and have since caged several neurotransmitters.
23,28,29
 More recently, 
Turro’s lab has investigated the ruthenium polypyridyl complexes for their potential as 
photodynamic drugs.
4,9
 Building on these and other Ru-caging examples,
3,12,28,30-32
 we set 
out to develop a Ru-photolinker amenable to caging oligos and other large biomolecules, 
with the goals of bypassing the harsh synthetic conditions typically required for ligand 
substitution at Ru
2+
, and avoiding direct reaction between biomolecules and Ru
2+
.  
 Here, we report the synthesis, characterization, and application of the first Ru-
photolinker, [Ru(bipyridine)2(3-ethynylpyridine)2]Cl2 (RuBEP) (Scheme 3-1). The bis-
alkyne functionality enabled circularization of an oligonucleotide containing azides at 
both 5′ and 3′ termini via [3+2] azide-alkyne copper(I)-mediated cycloaddition 
reactions.
33,34
 In this way, the octahedral Ru
2+
 center remained coordinatively saturated, 
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and side-reactions between Ru
2+
 and the nucleobases were avoided. Photolysis at 450 nm 
restored the linear, biologically active oligo (Scheme 3-1).  
 
II. Experimental procedures 
 
A. Synthesis of [Ru(bpy)2(3-ethynylpyridine)2](PF6)2 (RuBEP) 
 Ru(bpy)2Cl2 (101.8 mg, 0.20 mmol) and AgSO3CF3 (105 mg, 0.41 mmol)  were 
suspended in distilled methanol (10 mL). Solution was placed in the freezer overnight 
under nitrogen. The solution was then brought to rt, filtered to remove AgCl, and 3-
ethynylpyridine (3EP, 201.7 mg, 0.40 mmol) was added. The reaction was heated to 75 
o
C for 5 h until no further changes were observed by UV-Vis spectroscopy (Figure 3-1). 
The methanol was removed under reduced pressure and product was redissolved in 
boiling water. Solid ammonium hexafluorophosphate was added to the chilled solution 
until a light orange precipitate was formed. This was vacuum filtered, washed twice with 
cold water and dried. Compound was further purified by 1.5 x 15 cm silica column (230-
400 mesh) with 9:1 dichloromethane:acetonitrile as eluent and isolated in 71% yield  
(106.6 mg, 0.12 mmol). The water-soluble chloride salt was synthesized by addition of 
tetrabutylammoniom chloride to a solution of [Ru(bpy)2(3EP)2][PF6]2 dissolved in 
acetone. The synthetic scheme is shown in Scheme 3-2. 
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1
H NMR (500 MHz, CD3CN) 3.74 (s, 1H, 3EP-H5), 7.33 (dd, 1H, J = 7.9, 3EP-H3), 7.39 
(ddd, 1H, J = 6.7, bpy-H3), 7.82 (ddd, 1H, J = 6.4, bpy-H6), 7.90 (d, 1H, J = 5.4, bpy-H1), 
7.95 (dd, 1H, J = 5.8, 3EP-H2), 7.97 (dd, 1H, J = 7.6, bpy-H2), 8.19 (td, 1H, J = 7.9, bpy-
H7), 8.31 (d, 1H, J = 8.2, bpy-H4), 8.32 (d, 1H, J = 5.2, 3EP-H1), 8.38 (s, 1H, 3EP-H4), 
8.40 (d, 1H, J = 7.9, bpy-H5), 8.95 (d, 1H, J = 5.2, bpy-H8).  
 
13
C NMR (500 MHz, CD3CN) 78.8, 84.5, 122.8, 124.9, 125.2, 126.9, 128.7, 129.0, 
138.9, 139.2, 142.1, 153.5, 153.7, 154.5, 156.5, 158.6, 158.7. 
Anal. Calc. for C34H12N6RuP2F12: C, 65.90; H, 4.23; N, 13.56. Found: C, 66.2; H, 4.30; 
N, 13.7. MS(ES): m/2z 310.06, expected: m/2z 310.06 
 
B. Circularization procedure for DNA and morpholino 
 Reactions were performed on a 10 - 12 nmol  scale. Mono-azido DNA and bis-
azido DNA was purchased from Integrated DNA Technologies, Coralville, Iowa. Bis-
azido morpholinos (Figure 3-2) were custom ordered from GeneTools, Philomath, 
Oregon. Bis-azido oligonucleotides were premixed with RuBEP at the indicated 
stoichiometric ratios. Cu(I)Br  was dissolved in 3:1 DMSO/t-butanol to make a 0.1 M 
solution. TBTA ([(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine) (Anaspec, Freemont, 
CA) was dissolved in 3:1 DMSO/t-butanol to make a 0.1 M solution. Cu(I)Br and TBTA 
were mixed in a 1:2 ratio and preincubated. The azide/alkyne solution volume was 
adjusted to 25 µL (for morpholino reactions) and 50 µL (for DNA reactions). 12% v/v of 
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the Cu(I)Br/TBTA solution was added to the oligonucleotide solution. Table 3-1 shows 
relative stoichiometries for click reactions. Solutions were sparged with N2 and sealed 
tightly with parafilm. Reactions proceeded for 3 h (DNA) and 24-48 h (MO). 
Temperatures varying from RT to 55 °C were tested, and no significant correlation was 
found between temperature and product formation. Additionally, vortexing or not mixing 
did not seem to change product formation. After reaction completion, a NAP-5 desalting 
column (GE Healthcare) was used to remove unreacted RuBEP, Cu(I)Br, and TBTA. 
Circular product was stored in aqueous solution at -20 °C. 
 
Table 3-1. Stoichiometries for DNA and MO circularization reactions 
 
 
 
 
 
 
C. HPLC purification for N3-DNA, Ru-DNA, N3-DNA-N3, and Ru-cDNA 
 A gradient of increasing acetonitrile in 0.05 M triethylammonium acetate in H2O 
was used with a Zorbax reverse-phase C18 column (Table 3-2). The column was heated 
to 40 °C during purification. Product elution times are indicated on HPLC traces (Figure 
3-3). All purifications were performed on an Agilent 1200 Analytical HPLC using a 
diode-array detector at 260 nm. 
Reagent nmol 
Azido-oligo 10 - 12 nmol 
RuBEP 10.0 
Cu(1)Br 100.0 
TBTA 200.0 
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D. Gel-shift assay and PAGE analysis 
 DNA constructs (25 pmol) were analyzed on 15 % or 20% polyacrylamide, 7M 
urea gels using Ambion Loading Buffer II (Invitrogen, Grand Island, NY). Gels were run 
at 300 V for 45 min  and stained for 15 minutes with EtBr. Gels were imaged with a 
Typhoon FLA 7000 imaging system (GE Healthcare Life Sciences, Pittsburgh, PA). 
 Morpholino constructs (25 pmol) were analyzed using a gel-shift assay. 15% or 
20% polyacrylamide, native gels were run with NativePAGE Sample Buffer (4x) 
(Invitrogen, Grand Island, NY). Running buffer (1X TBE) was cooled to 10 °C on ice 
and cast gel was preincubated in cold buffer before loading. Samples were prehybridized 
by heating to 80 °C for 40 minutes and immediately cooled in an ice bath for 10 min. 
Gels were run in an ice bath for 120 min at 100 V and subsequently stained for 15 
minutes with EtBr. Gels were imaged with a Typhoon FLA 7000 imaging system (GE 
Healthcare Life Sciences, Pittsburgh, PA). 
 
E. Light Sources 
 A Luxeon III Star® Royal Blue© LED was used for uncaging experiments, 
purchased from Quadica Developments Inc. (Ontario, Canada). Power measured at the 
sample was 14 mW/cm
2
 with a maximum output wavelength of 450 nm. 
 A Sapphire Galaxy Blue handheld laser was purchased from Beam of Light 
Technologies (Oregon, USA) and used to determine the quantum yield of RuBEP. Power 
measured at the sample was 53 mW/cm
2
, with a maximum output wavelength of 450 nm.  
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F. Molecular beacon hybridization assay 
 A molecular beacon complementary to bis-azido oligo sequence was designed, 
with fluorophore, 6-FAM on the 5′ end, quencher, BHQ1 on the 3′ end and a 6-nt 
complementary stem (Table 3-7). Caging was monitored by the opening of the molecular 
beacon in the presence of oligonucleotide. Circular oligo was hybridized to the molecular 
beacon, excited at 494 nm, and fluorescence intensity at 523 nm was quantified. For 
comparison, the fully complementary linear bis-azido oligo as well as a mismatch 
sequence, were also monitored. The circular oligo was then exposed to 450 nm light (3 
min 14 mW/cm
2
), and rehybridized to the molecular beacon. All solutions were made to 
1 pmol/µL with a 50 µL volume. All samples were prehybridized prior to analysis, by 
heating to 80 °C for 30 min, and immediately incubated on ice for 10 min. Samples were 
analyzed at 10 °C. 
 
Table 3-2. Gradient used for Ru-DNA and Ru-cDNA HPLC purification 
 
 
 
 
G. Zebrafish microinjection experimental details 
 Zebrafish embryos were obtained from the CDB Zebrafish Core Facilty at the 
University of Pennsylvania Perelman School of Medicine. All embryos obtained were 
TLF x TLF (WT). Zebrafish embryo injection solutions were prepared to contain a final 
Time (min) % Acetonitrile % 0.05 M TEAA 
0.0 90 10 
40.0 40 60 
50.0 20 80 
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concentration of 0.1 M KCl and 0.25% phenol red dye. All injections were performed at 
the one-cell stage and injected into the cell compartment only. A Harvard Apparatus PLI-
100 pico-injector was used to inject controlled volumes. Injection volume was calibrated 
to dispense 5 nL per embryo. Zebrafish embryos were incubated at 28 °C in E3 zebrafish 
medium. All embryos were incubated in the dark, except for irradiated samples, which 
were exposed to 450 nm light (14 mW/cm
2
) for the stated time and returned to the dark 
incubator. Embryo micrographs were collected at 24 hpf with an Olympus FV1000 laser 
scanning confocal microscope using transmitted light imaging. A 10x air objective was 
used for single embryo imaging and 4x air objective was used for multiple embryo 
imaging. 
 
H. Materials 
 Organic reagents and solvents were used as purchased from the following 
chemical sources: Methanol, methylene chloride (HPLC grade), acetonitrile (HPLC 
grade), and acetone were purchased from Fisher Scientific. Cis-dichloro-bis(2,2’-
bipyridine)ruthenium(II) (98%), 3-ethynylpyridine (96%), silver trifluoromethansulfonate 
(99+%),  ammonium hexafluorophosphate (99.5%), acetonitrile-d
3
 (99.8 atom%), 
tetrabutylammonium chloride hydrate (98%), deuterium oxide (99.8 atom%) were 
purchased from Acros Organics. 
 Complementary DNA oligonucleotides, azido-DNA oligonucleotides, and 
molecular beacons were custom synthesized and HPLC purified by Integrated DNA 
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technologies (Coralville, IA). Azido-MOs were custom synthesized by Gene Tools 
(Philomath, Oregon). All gel reagents were purchased from Bio-Rad (Hercules, CA). 
TBTA ligand (Tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine) was purchased 
through Anaspec (Fremont, CA). Zebrafish embryos were obtained through the CDB 
Zebrafish Core Facilty at the University of Pennsylvania Perelman School of Medicine. 
 
I. Instrumentation 
 A Luxeon III Star® Royal Blue© LED was used for uncaging experiments post-
click reactions, including in vivo work. It was purchased from Quadica Developments 
Inc. (Ontario, Canada) with a maximum output wavelength of 450 nm. Measured power 
at sample was 14 mW/cm
2
.  
 A sapphire Galaxy Blue handheld laser was purchased from Beam of Light 
Technologies (Oregon, USA) and used to determine the quantum yield of RuBEP. 
Measured power at the sample was 53 mW/cm
2
, with a maximum output wavelength of 
450 nm.  
 UV-Visible spectroscopy was performed using an Agilent 8453 UV-Visible 
spectrometer (Agilent Technologies, Germany) in water unless otherwise specified. 
1
H 
NMR spectra were obtained on a Bruker DMX 500 spectrometer, and 
13
C NMR spectra 
were obtained using a Bruker AVIII cryo500 probe spectrometer at the University of 
Pennsylvania NMR facility and were recorded at room temperature. The 
1
H and 
13
C 
spectra were referenced to the central line of the solvent residual or to TMS at 0.00 ppm. 
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1
H
 
NMR and 
13
C NMR chemical shifts () are given in parts per million and reported to a 
precision of ± 0.01 and ± 0.1 ppm, respectively. Proton coupling constants (J) are given 
in Hz and reported to a precision of ± 0.1 Hz. 
 High-resolution mass spectra (HRMS) were obtained using electrospray 
ionization (ESI) mass spectrometry on a Micromass Autospec at the Mass Spectrometry 
Facility in the Department of Chemistry at the University of Pennsylvania. Irradiated 
sample was analyzed via direct infusion nanospray with a Thermo ORBI trap XL mass 
spectrometer at 60 K resolution. Gels were imaged with a Typhoon FLA 7000 imaging 
system (GE Healthcare Life Sciences, Pittsburgh, PA). 
 All purifications were performed on an Agilent 1200 Analytical HPLC using a 
diode-array detector set to 260 nm. A 5-micron  Zorbax semi-preparatory C18 column 
(9.4 x 215 mm) was used for all reverse-phase purifications. 
 
 
 
 
 95 
 
 
 
Scheme 3-1. RuBEP conjugation and irradiation  
Photolinker RuBEP conjugation with 25mer bis-azido morpholino to form “caged” antisense MO. 
1,4-regioisomers of 1,2,3-triazoles are the sole product of the copper(I)-catalyzed azide-alkyne 
cycloaddition (CuAAC). Subsequent 450-nm irradiation restores biologically active MO. 
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Scheme 3-2. Synthetic scheme of RuBEP 
RuBEP was synthesized from Ru(bpy)2Cl2 via a two-step synthesis. 
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Figure 3-1. UV/Vis monitoring product formation  
UV-Vis spectra of RuBEP synthesis  reacted in methanolat75 
o
C. The peak at 520 nm was due to 
Rubpy2OTf, which disappeared as RuBEP was formed to give the double peak near 450 nm. 
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Figure 3-2. Structure of bis-azido morpholino 
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Figure 3-3. HPLC traces for N3-DNA.  
A) N3-DNA eluted at 25.0 min and B) Ru-DNA after click reaction eluted at 22.3 and 24.1 min 
using gradient shown in Table 3-2. 
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Figure 3-4. HPLC traces for N3-DNA-N3  
A) N3-DNA-N3 eluted at 27.5 min and B) Ru-cDNA after click reaction eluted at 22.5 min using 
gradient shown in Table 3-2. 
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III. Results and Discussion 
 
A. RuBEP 
 The RuBEP photolinker was synthesized from Ru(bpy)2Cl2 and 3-ethynylpyridine 
(3EP) by modifying a published procedure.
9
 Reaction progress was monitored by the 
appearance of an MLCT band at 450 nm (Figure 3-1). Precipitation with 
tetrabutylammonium chloride produced the water-soluble chloride salt, RuBEP, which 
was characterized by X-ray crystallography (Appendix A), ESI-MS (Figure 3-6), 
1
H and 
13
C NMR (Figure 3-7), and elemental. X-ray crystallography revealed a 92° angle 
between alkyne linkers, confirming correct geometry for circularization applications 
(Figure A1-1). 
 Photodissociation of the 3-ethynylpyridine ligand from RuBEP was monitored by 
LCMS (Figure 3-6), UV-Vis (Figure 3-5) and NMR (Figure 3-7) spectroscopies. Upon 
continuous irradiation of RuBEP in water with 450 nm light (53 mW/cm
2
), the λmax red-
shifted from 450 nm to 473 nm (Figure 3-5). Photolysis of the bulk RuBEP solution (80 
µM) was detectable within the first 20 s, with complete dissociation in 5 min. In addition 
to the wavelength shift, a very obvious color change was also present, as shown in Figure 
3-5, inset. The orange photo-product ([Ru(bpy)2(3EP)(OH2)]
2+
) was consistent with 
previously characterized [Ru(bpy)2(pyr)(OH2)]
2+
 complexes.
35
 Two isosbestic points 
were observed (Figure 3-5), consistent with the exchange of one ligand for a solvent.
24
  
1
H NMR also showed the exchange of only one 3EP ligand with a solvent water 
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molecule, based on an observed shift in alkyne peak and change in integration (Figure 3-
7). HR-MS also confirmed the photoproduct assignment with a mass change from 620 Da 
to 552 Da (Figure 3-6).  
 To probe toxicity of RuBEP in vivo, 1-cell stage zebrafish embryos were 
microinjected with 1 mM RuBEP and subjected to either 450 nm light (14 mW/cm
2
, 5 
min), or incubated in the dark. Concentrations for in vivo experiments are significantly 
lower than this concentration, typically 0.1 - 0.5 mM. Both batches of embryos were 
observed to remain healthy and develop normally, whether incubated in the dark or 
irradiated with visible light, and survival rates were comparable to the uninjected control.  
 To  determine the efficiency of ligand exchange, the quantum yield in water under 
ambient oxygen (φ= 0.33 +/- 0.06) was determined by fitting the initial kinetics of the 
photoreaction (Figure 3-8). The quantum yield for RuBEP was determined to be 
comparable to the quantum yield of ligand exchange measured for 
Ru(bpy)2(pyridine)2Cl2, showing that the electronics of the added alkyne does not have 
much effect on the efficiency.
25
 The uncaging efficiency for RuBEP—defined as ε450 
times φ—was determined to be 2.0 x 103 M-1cm-1 at 450 nm, which is much higher than 
measured for typical organic chromophores activated at near-UV wavelengths. 
Commonly used nitrobenzyl derivitives, such as the o-nitrobenzyl caging group used in 
previous caging methods in our lab have 1-P uncaging efficiencies  less than 100 M
-1
cm
-2 
at 365 nm.
4,36
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B. Ru-cDNA 
 Initial efforts in circularization were focused on using a DNA oligonucleotide. 
Although DNA does not have antisense activity in zebrafish embryos, the use of DNA 
allowed for proof-of-concept experiments and protocol development due to ease of 
solubility and ability to purify using reverse-phase HPLC. Using RuBEP as photolinker, 
circularization protocols were initially investigated using a bis-azido 25mer DNA 
oligonucleotide.  
 The [3+2] Cu(I)-mediated cycloaddition reaction was performed at a 
stoichiometry of 1.2 DNA:1 RuBEP, and monitored by polyacrylamide gel 
electrophoresis. A time-course gel was used to follow reaction progression and product 
formation. A band migrating faster than the bis-azido DNA appeared within the first 15 
min of reaction (Figure 3-9). A faster migrating band is consistent with circularization, as 
a more compact, circular structure would have  this effect. Additionally, the positive 
charge contributed by RuBEP could also play a role in gel migration speed. To confirm 
that this was the Ru circularized DNA (Ru-cDNA) and not RuBEP clicked to two linear 
DNA oligos (DNA-RuBEP-DNA), a mono-azido DNA was subjected to the same 
reaction conditions, which resulted in a slower migrating band (Figure 3-10).  
 In addition to circular product, formation of polymer and dimer also occurred. 
This is especially apparent with the bis-azido DNA (Figure 3-9, lanes 2-3), which is 
expected due to the two azides. Although the 1.2:1 DNA to RuBEP stoichiometry should 
favor only one linker per oligo and subsequent circularization, other 1:1 structures could 
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form as well such as Ru-DNA-Ru-DNA, and an equal combination of RuBEP-DNA-
RuBEP and DNA-RuBEP-DNA. These side products became less apparent on the gel 
after the first 30 minutes of reaction (Figure 3-9) which is likely because these RuBEP-
DNA polymers were less soluble and didn't remain in solution with extended reaction 
times. The mono-clicked product is visible on the gel in the first 15 minutes (Figure 3-9, 
Lane 2), showing that initially one side reacts, and then due to stoichiometry and 
concentration favoring circularization, an intramolecular reaction occurs. As expected, 
significantly less polymer formation was formed with the mono-azide DNA reaction than 
with RuBEP (Figure 3-10, Lane 2). A secondary band migrating slower than the linear 
Ru-DNA was the only significant side product, likely a DNA-RuBEP-DNA dimer due to 
the presence of two alkynes on RuBEP.  
 The reaction products for both the Ru-cDNA and Ru-DNA were readily isolated 
by reverse-phase HPLC (Figures 3-3 A-B, Table 3-2). The retention times for the mono-
azide and bis-azido DNA differed by 2.5 min (25.0 vs 27.5 min for mono- vs. bis-azido 
DNA). However, retention time for both Ru-DNA and Ru-cDNA were both very similar 
(22.3 vs 22.5 min for Ru-DNA vs Ru-cDNA). These two constructs are very similar in 
many aspects such as hydrophobicity, charge, and molecular weight, making HPLC 
separation very challenging with reverse phase and ion-exchange methods. To 
circumvent this, reaction conditions were optimized so that no Ru-DNA remained in the 
Ru-cDNA reaction. The Ru-cDNA and Ru-DNA could be readily separated from other 
reaction products using reverse-phase HPLC. Figure 3-11 shows successful isolation of 
 105 
 
pure Ru-cDNA after HPLC purification. Circularization occurred with greater than 80% 
efficiency (determined by gel band intensity quantification) and approximately 25% was 
recovered after HPLC purification. 
 To probe circularization and caging, a molecular beacon (MB) complementary to 
the N3-DNA-N3 sequence was designed with fluorophore 6-FAM on the 5′ end and 
quencher BHQ1 on the 3′ end, with a 6-nt complementary stem (Table 3-7). A calibration 
curve was made with DNA:MB ratios of 0:1 to 5:1 to confirm opening of the molecular 
beacon with complementary bis-azido DNA (Figure 3-12). With RuBEP holding the 
25mer DNA in a circular conformation, the ability to fully hybridize to a complementary 
DNA is hindered. Four different conditions were tested. MB with a scrambled sequence 
MB with a fully complementary bis-azido linear sequence, MB with Ru-cDNA, and MB 
with Ru-cDNA exposed to 450 nm (14 mW/cm
2
, 5 min) (Table 3-7). Caging, indicative 
of circularization, was monitored by the opening of the molecular beacon in the presence 
of oligonucleotide. Ru-cDNA was hybridized to the molecular beacon, and fluorescence 
intensity at 523 nm was quantified. Fluorescence intensity for the linear DNA was 
normalized to 100% (Figure 3-13). For comparison, the fully complementary linear bis-
azido DNA as well as a DNA scramble sequence were also monitored. Circularization 
and caging of the Ru-cDNA was confirmed by a 2.3-fold lower fluorescence intensity 
when compared to the linear complementary DNA (Table 3-3), under thermal annealing 
conditions that greatly favored hybridization. After visible light exposure, fluorescence 
intensity was restored to match the intensity of the bis-azido complementary DNA. This 
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confirms complete uncaging and hybridization restoration upon short exposure to blue 
light.  
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Figure 3-5. Change in UV-Vis spectrum of RuBEP upon 450-nm focal irradiation.  
RuBEP in H2O was continuously irradiated with 450 nm (53 mW/cm
2
) and wavelength shift was 
monitored. Two isosbestic points were detected. A yellow to orange color change was visible 
upon ligand exchange (inset). 
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Figure 3-6. Electrospray mass spectrometry of [RuBEP])PF6)2 +/- light 
A)  RuBEP PF6 salt before irradiation, showing a doubly charged species at 310.06 Da. Expected 
mass = 620.13 Da (z=1), 310.06 Da (z=2)  B) RuBEP + 450 nm (5 min, 14 mW/cm
2
) showing 
singly charged species at 552.05 Da, confirming the exchange of one 3EP ligand upon irradiation. 
Expected mass = 552.02 Da (z=1) 
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A      
 
B 
 
Figure 3-7. 
1
H NMR, pre- and post-photolysis of RuBEP in D2O. 
A)  Pre-photolysis 1H NMR. B)  Post-photolysis 1H NMR (+450 nm, 5 min, 14 mW/cm2) 
showing the appearance of a free 3-EP peak, and change in integration for bound 3-EP peak. The 
appearance of a second alkyne peak confirms one ligand exchange with solvent (D2O). 
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Figure 3-8. Quantuim yield determination of RuBEP. 
A)  Kinetics trace of ligand dissociation of 14 μM RuBEP (0.2 OD) upon exposure 450 nm laser 
(53 mW/cm
2
) under ambient conditions. Abs473 was monitored to determine formation of product, 
Ru(bpy)2(3-EP)(H2O)Cl2 . B)  Equations for quantum yield of photorelease calculation. Quantum 
yield was determined to be 0.33 ± 0.06. 
 
 
Moles Product Ru(bpy)23EP(OH2) = initial moles RuBEP – current moles RuBEP (1) 
current moles RuBEP    
Abs-εp[RuBEP]i
εs-εp
   cuvet (2) 
photons absorbed  
E
Pl
 (3) 
Where: 
  
P
l
 = net power of the laser during the trial (mW) 
E = energy of 450 nm light (J/photon) 
s = extinction coefficient of RuBEP (starting material) at 475 nm = 1800 M
-1
cm
-1
 
p = extinction coefficient of Rubpy2(3EP)(H2O) (product) at 475 nm = 3800 M
-1
cm
-1 
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Figure 3-9. Time-course gel of DNA circularization 
25 pmol aliquots were removed over the course of the DNA circularization reaction. Each aliquot 
was run on a 15% PAGE/ 7M urea gel at 300 V for 45 min and stained for 15 min with EtBr. 
Click reaction aliquots were compared to the linear bis-azido DNA migration (lanes 1, 4, 6, 8). 
Circular product appeared as the fastest migrating band, within the first 15 min of the reaction, 
with more product formation at 3 h (lane 9). 
 
1 – N
3
-DNA-N
3
 
2 – 15 min rxn 
3 – 30 min rxn 
   1     2      3               4     5                6     7             8     9 
4 – N
3
-DNA-N
3
 
5 – 1 h rxn 
6 – N
3
-DNA-N
3
 
7 – 2 h rxn 
8 – N
3
-DNA-N
3
 
9 – 3 h rxn 
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Figure 3-10. Mono-azide DNA click reaction 
Lane 1 – N
3
-DNA only, Lane 2 – N
3
-DNA clicked, Lane 3 – N
3
-DNA clicked + 450 nm light. 
A mono-azido DNA 25mer was subjected to the same conditions given above for the bis-azide 
DNA. The circularization efficiency was monitored on a 15% PAGE/7 M urea gel, run for 45 min 
at 300 V. The gel was stained for 15 min with EtBr. A band (lane 3) running slower than the N3-
DNA appeared, and intensity was decreased after photolysis. Only 50% decrease in photoloysis 
was seen, as only one 3EP ligand on RuBEP will exchange upon light exposure. The higher band 
in lane 2 is likely dimer, DNA-RuBEP-DNA. 
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Figure 3-11. 20%, 7 M urea PAGE analysis of Ru-cDNA after HPLC purification 
HPLC isolation of Ru-cDNA from Figure 3-4B. Lane 1. N
3
-DNA-N
3 
(TR = 27.5), Lane 2. Ru-
cDNA after HPLC purification (TR = 22.5 min) 
 
  
 
 
 
 
 
 
 
 
1      2 
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Figure 3-12. Calibration curve for molecular beacon targeting ntl 
To confirm opening of MB in presence of fully complementary MO, linear ntl-MO was 
hybridized to MB in ratios ranging from 0.1:1 to 5:1 and fluorescence intensity was measured at 
523 nmafter thermal annealing. 
 
 
 
 
 
 
 
0 
50 
100 
150 
200 
250 
300 
350 
400 
450 
0 1 2 3 4 5 6 
In
te
n
si
ty
 a
t 
5
2
3
 n
m
 
DNA:MB molar ratio 
 115 
 
 
 
Figure 3-13. Molecular beacon hybridization assay for Ru-cDNA 
Molecular beacon fluorescence assay showing less probe hybridization to caged Ru-cDNA 
compared to the linear DNA or Ru-cDNA after 3-min exposure to 450-nm light. Samples were 
annealed prior to molecular beacon assay to promote hybridization. 
 
 
Table 3-3. Relative fluorescence intensities for molecular beacon targeting ntl-DNA 
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C. Ru-cMO 
 In order to photoregulate gene expression in living zebrafish embryos, two early 
developmental zebrafish genes were targeted, notail (ntl) and chordin (chd), due to their 
well characterized and easily recognizable knockdown phenotypes with antisense MOs.
37
 
Examples of these knockdown phenotypes are shown in Figures 3-14 and 3-15. Upon 
knocking down chd with an antisense MO, zebrafish embryos will develop with a 
decreased head size, U-shaped somites, and a large "blood island" on the tail (Figure 3-
14). Knocking down ntl with an antisense morpholino results in zebrafish embryos with a 
decreased head size, U-shaped somites, no notochord, and no posterior structures. These 
phenotypes can range from mild to severe depending on the morpholino dose. Control 
morpholino doses for both chd and ntl were titrated by injecting varying concentrations 
of morpholino to achieve the strongest phenotype while limiting toxicity and off-target 
effects. These optimal concentrations were found to be 0.5 mM and 0.25 mM for chd and 
ntl, respectively. 
 The RuBEP-DNA circularization conditions were subsequently applied to 
antisense MOs (Scheme 3-1). Bis-azido MOs were purchased from Gene Tools 
(Philomath, OR) and added to RuBEP in a 1.05:1 ratio in the presence of 10x Cu(I)Br 
and 20x chelator, TBTA (Table 3-1). These reaction conditions promoted reaction of one 
RuBEP per MO, thus favoring intramolecular reaction and circularization. Reaction 
conditions varied slightly depending on sequence, as solubility of morpholinos is related 
to the number of guanine residues in the sequence. For chd, 10.5 nmol MO was added to 
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10 nmol RuBEP in 25 µL. The reaction volume for ntl was increased to 100 µL to 
increase solubility (due to higher guanine content). The reaction proceeded for 24-48 h at 
rt. Although product was formed within the first 15 minutes of the reaction, product was 
maximized after 24-48 h (Figure 3-18). 
 Due to the neutral charge of morpholinos, the click product, Ru-cMO could not be 
analyzed using standard PAGE or HPLC as Ru-cDNA was. Instead, formation of Ru-
cMO was monitored by gel-shift assay employing a 25mer complementary DNA strand. 
The control MO or Ru-cMO was hybridized to a complementary DNA to provide charge 
density for gel migration. This MO:DNA hybrid was run on a 15% native polyacrylamide 
gel on ice (100 V, 120 min) and stained with ethidium bromide, shown in Figure 3-16. As 
expected, the complementary DNA (lane 1) ran slower when hybridized to linear bis-
azido MO (lane 2). Upon circularization (lane 3), the Ru-cMO:DNA hybrid migrated 
even slower, which can be attributed to its weaker duplex stability. An additional band 
(band 4) is seen in lane 3 likely due to the less stable duplex causing dehybridization of 
some DNA during the gel-shift assay. Photoactivation at 450 nm (14 mW/cm
2
, 3 min) 
resulted in complete uncaging, yielding a mono-Ru-functionalized linear MO that was 
hybridized to DNA (lane 4) and ran comparably to the MO:DNA hybrid (lane 2). All 
lanes contained stoichiometric complementary DNA (lowest band) to promote 
hybridization. For Ru-cMO-chd, QuantIT band quantification showed less than 5% 
unreacted bis-azido MO after 48-h RuBEP reaction (Figure 3-16). Typical reaction yields 
ranged from 87–95% circularization, determined by band size and intensity 
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quantification. No additional purification of Ru-cMO was necessary due to high 
circularization efficiency. Reaction efficiency for Ru-cMO-ntl was slightly lower and 
contained a linear Ru-MO side reaction, due to mono-azido MO impurity in the bis-azido 
MO obtained from Gene Tools (Figure 3-17). 
 A molecular beacon was designed targeting chd-MO, with a fluorophore (5'-
FAM) and quencher (3'-BHQ1), and 6-nt complementary stem (Table 3-7). The 
molecular beacon fluorescence assay was performed to confirm caging of the Ru-cMO-
chd construct. Fluorescence signal from the molecular beacon  was very strong when 
hybridized to linear MO (Figure 3-19), setting the baseline for this measurement. By 
comparison, fluorescence intensity was 2.6-fold lower with Ru-cMO-chd, indicative of 
caging. After exposure to 450 nm light (14 mW/cm
2
, 3 min) the fluorescence intensity 
was restored within error of the linear MO, confirming complete uncaging. These data 
agreed well with the gel-shift assay (Figure 3-16) which also showed that some 
hybridization occurred, although to a lesser extent than the linear control. This can be 
attributed to forced hybridization through heating and cooling in both the gel and the 
molecular beacon assay. 
 The circular construct, Ru-cMO-chd, was tested in vivo in living zebrafish 
embryos to assess the ability to photoregulate gene expression with RuBEP caged 
morpholinos. Ru-cMO-chd (514 pmol/µL) was microinjected into zebrafish embryos at 
the one-cell stage. Half of the injected embryos were incubated at 28 °C in the dark, 
while the other half were irradiated with 450 nm light (14 mW/cm
2
, 5 min). Another 
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batch of embryos were injected with control linear bis-azido MO targeting chd at the 
same concentration. At 24 hpf, the embryos were scored for phenotypic response (Table 
3-4) and imaged.
38
 Figure 3-20(A-D, E) shows representative images of the phenotypic 
response and embryo phenotype scoring at 24 hpf. Figure 3-20A shows the uninjected 
control emrbyos, where 100% developed as expected for wildtype TLF x TLF zebrafish. 
In contrast, Figure 3-20D shows embryos injected with the control linear MO. These 
embryos developed with varying degrees of chd knockdown phenotype, with 95% 
showing a severe or moderate phenotype. A small percentage of these embryos (5%) 
developed normally, which can be attributed to injection error. Embryos injected with 
Ru-cMO-chd followed similar phenotypic trends as the controls. For the embryos 
incubated in the dark, >86% developed normally, comparable to the uninjected control. 
Embryos exposed to blue light developed similarly to the linear MO-chd control 
injection. Over 92% of the embryos developed with the chd knockdown phenotype, with 
greater than half of the embryos displaying a severe phenotype as was seen with the 
linear MO-chd control. This confirms that the retained Ru moiety on the uncaged MO 
does not affect MO activity in vivo. This is consistent with the molecular beacon assay, 
where Ru-cMO after uncaging behaved identical to linear bis-azido MO. The 8% of 
embryos with normal development can be attributed to injection variability. 
 To confirm sequence-specificity, identical experiments were performed with a 
second gene, ntl
39
 (Figure 3-21). Similar caging results were obtained with Ru-cMO-ntl, 
however, background MO activity was slightly higher. Of the embryos incubated in the 
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dark, 4% developed with class IV phenotype (severe), however, a significant percentage 
(26%) developed with a class II phenotype. This background activity can be attributed to 
the linear Ru-MO due to the mono-azide impurity in the starting material from Gene 
Tools (Figure 3-17). The embryos irradiated with blue light developed with varying 
degrees of the ntl phenotype. 
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Figure 3-14. chd-MO knockdown phenotype 
The no-chordin phenotype ranged from severe to mild where severe was identified by a 
significantly decreased head size, U-shaped somites, and a large blood island on the tail. 
Moderate and mild phenotypes were both identified by U-shaped somites and blood island, to 
varying degrees.  
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   Normal WT (Class 1)        Class 2                Class 3       Class 4 
 
Figure 3-15. ntl-MO knockdown phenotype 
Zebrafish embryos were injected at the 1-cell stage with 0.25 mM ntl-MO and imaged at 24 hpf. 
The notail morpholino knockdown phenotype ranged from severe (class 4) to mild (class 2) 
where severe is identified by a significantly decreased head size, U-shaped somites, no notochord, 
and no posterior structures. Class 3 is identified by U-shaped somites, no notochord, and 
significantly shortened posterior structures. Class 2 is identified by U-shaped somites, a shortened 
posterior axis, with the notochord still present. 
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Figure 3-16. Gel-shift assay showing Ru-cMO formation and photolysis 
15% native PAGE gel-shift assay showing formation of Ru-cMO-chd (lane 3), and subsequent 
photolysis with 450 nm light (14 mW/cm
2
, 3 min) (lane 4). Complementary DNA and DNA/MO 
hybrid controls are show in lanes 1 and 2, respectively. Lane numbers are shown in black and 
band numbers are shown in red. 
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Figure 3-17. ntl-MO circularization 
15% native PAGE gel-shift assay showing controls (lanes 1 and 2) and formation of Ru-cMO-ntl 
(lane 3). Circular product is indicated by the arrow. No additional purification was performed 
before in vivo testing. Due to initial impurities of bis-azido-ntl MO, the same circularization 
efficiency could not be achieved as with bis-azido-chd MO. Lane 1. complementary DNA,  Lane 
2. DNA: ntl MO hybrid,  Lane 3. Click reaction 1.05:1 (MO: RuBEP), RT, 24 h. Lane numbers 
are shown in black and band numbers are shown in red.  Band 4 represents complementary DNA, 
band 3 represents a singly clicked impurity as a result of initial N3-MO impurity, band 2 
represents Ru-cMO product, and band 1 represents dimerized product. 
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Figure 3-18. Time course gel-shift for Ru-cMO-ntl  
15% native PAGE gel-shift assay showing controls (lanes 1 and 2) and formation of Ru-cMO-ntl 
(lanes 3-8). Circular product formation was monitored over a range of 15 min to 24 h. Lane 1: 
complementary DNA, lane 2: DNA/ntl MO hybrid, lane 3: 15 min rxn, lane 4: 30 min rxn, lane 5: 
1 h rxn, lane 6: 6 h rxn, lane 7: 16 h rxn, lane 8: 24 h rxn. Band assignments are outlined in 
Figure 3-17. 
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Figure 3-19. Molecular beacon assay showing Ru-cMO-chd caging 
Molecular beacon fluorescence assay showing less probe hybridization to caged Ru-cMO 
compared to the linear MO or Ru-cMO after 3-min exposure to 450-nm light. Samples were 
annealed prior to molecular beacon assay to promote hybridization. 
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Figure 3-20. in vivo testing of Ru-cMO-chd  
Representative images of 24-28 hpf zebrafish embryos, showing different degrees of chd 
knockdown phenotype: A) Wildtype control embryo, uninjected. B) Ru-cMO-chd, incubated in 
the dark, showing normal development. C) Ru-cMO-chd, irradiated for 5 min at 1 hpf with 450-
nm light, showing no-chordin phenotype. D) Bis-azido morpholino control showing no-chordin 
phenotype. All embryos were injected at 1-cell stage. E)  Percent of embryos showing each of 
four phenotypic responses.  
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Figure 3-21. Ru-cMO-ntl in vivo data 
Zebrafish embryos were injected with MO control at the 1-cell stage with 0.25 mM ntl-MO and 
imaged at 24 hpf. For Ru-cMO, zebrafish embryos were injected at the 1-cell stage with 0.25 mM 
Ru-cMO-ntl. Half of the embyros were irradiated (450 nm, 14 mW/cm
2
, 5 min) at 1 hpf, while 
the other half were incubated in the dark. Embryos were scored for phenotype at 24 hpf. 
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Table 3-4. Phenotypic scoring for Ru-cMO-chd in vivo 
 
Wildtype Ru-cMO -h  Ru-cMO +h MO control 
n value >100 94 66 78 
Normal 100.0% 86.2% 7.6% 5.3% 
Mild 0.0% 4.3% 10.6% 0.0% 
Moderate 0.0% 5.3% 31.8% 46.7% 
Severe 0.0% 4.3% 50.0% 48.0% 
 
 
Table 3-5. Phenotypic scoring for Ru-cMO-ntl in vivo 
 
 
Wildtype Ru-cMO -h Ru-cMO +h MO control 
n value >100 26 23 44 
Class I 100.0% 69.2% 17.4% 2.3% 
Class II 0.0% 26.9% 21.7% 2.3% 
Class III 0.0% 0.0% 43.5% 45.5% 
Class IV 0.0% 3.8% 17.4% 50.0% 
 
 
Table 3-6. Ru-cMO MALDI data.  
Samples were analyzed using 3-hydroxypicolinic acid (3-HPA) matrix in linear positive ion mode 
on a Bruker Ultraflex III MALDI TOF/TOF mass spectrometer. 
 
 
 Expected mass (Da) MALDI mass (Da) 
Ru-cMO-chd 9561 9567 
Ru-cMO-ntl 9357 9385 
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Table 3-7. Oligonucleotide sequences, 5′ to 3′ 
 
DNA GACTTGAGGCAGGCATATTTCCGAT 
Reverse 
complement 
ATCGGAAATATGCCTGCCTCAAGTC 
Molecular 
beacon 
6FAM-CCACCCATCGGAAATATGCCTGCCTCAAGTCGGGTGG-
BHQ1 
chd-MO ATCCACAGCAGCCCCTCCATCATCC 
chd reverse 
complement 
GGATGATGGAGGGGCTGCTGTGGAT 
chd molecular 
beacon 
6FAM- 
CGGGCGGGATGATGGAGGGGCTGCTGTGGATCGCCCG-BHQ1 
ntl-MO* AGCTTGAGATAAGTCCGACGATCCT 
ntl reverse 
complement 
AGGATCGTCGGACTTATCTCAAGCT 
DNA scramble AAAAAAAAAAAAAAAAAAAAAAAAA 
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IV. Conclusion 
 The first example of a ruthenium photolinker, RuBEP, was synthesized and 
characterized. RuBEP can be synthesized in high yields with a two-step synthesis. 
RuBEP undergoes ligand dissociation with a high quantum yield upon exposure to 450 
nm light. This ligand exchange is very clean and efficient, making RuBEP an optimal 
photolinker for use in biological systems, and thus, RuBEP was used to cage DNA and 
MO oligonuclotides. The alkyne groups on the 3-ethynylpyridine ligands reacted with 
bis-azide-functionalized oligonucleotides to form cyclized, caged oligos in good yields 
and purity. These Ru-circularized oligos underwent efficient Ru
2+
-ligand exchange upon 
450-nm irradiation, to reveal the linear oligonucleotides. Ru-cMOs were tested in vivo 
and efficient caging of antisense activity was achieved when the oligo was circularized. 
Biological activity was restored upon 450 nm irradiation revealing the expected antisense 
knockdown phenotypes in zebrafish embryos. Complete restoration of biological activity 
confirmed that the pendant Ru
2+
 moiety did not adversely affect target hybridization or 
biological activity (Figure 3-20E). In addition to the broad in vivo applications for Ru-
morpholinos, it is expected that RuBEP can be used to cage many other azide-
functionalized biomolecules, e.g., peptides, lipids, oligosaccharides. Finally, the versatile 
1-P and 2-P inorganic photochemistry of [Ru(bipyridine)2(X)2]
2+
 complexes motivates  
further development of Ru photolinkers to allow multiplexed caging/uncaging for diverse 
applications. 
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I. Introduction 
 The caging and precise spatiotemporal release of bio-active compounds is 
becoming increasingly important in the field of nanomedicine. A particular focus has 
been the development of chemical cages for metal ions, such as Zn
2+
 and Ca
2+
. Zinc is 
required for normal cell function and important for both intracellular and extracellular 
signaling. Lack of zinc homeostasis can retard growth and lead to immunodeficiency.
1-3
 
The biological importance of Ca
2+
 has been studied extensively in muscle contraction, 
cell signaling, gene regulation, thrombosis, wound healing, and cell death.
4
 Deficiencies 
in zinc and calcium are common in the human population, and can lead to many 
neurological, cardiovascular, and endocrine disorders.
4,5
 Strategies for further probing the 
biological functions of these metal ions involve metal ion delivery to localized sites, 
which has the advantage of avoiding homeostatic disruption in non-target areas.  
 Traditional approaches for caging metal ions have employed inorganic 
coordination chemistry, where one or more multivalent ligands coordinates the metal ion, 
and the release of the caged ion is achieved by modulating the dissociation constant, KD, 
for the ligand-metal ion complex. A family of ligands has been developed for Zn
2+
 and 
Ca
2+
 with weak and strong affinities.
4,6-8
 A common challenge with small-molecule 
ligands is the lack of specificity where similar ions can compete for binding to the active 
site.
8
 An extension of the thermodynamically-driven release of metal ions is 
incorporation of stimulus responsiveness. Light has been used in conjunction with 
coordination chemistry to provide a binary system that switches from caged to uncaged 
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for both Zn
2+
 and Ca
2+
. In these systems, photoactive moieties such as o-nitrobenzyl, 
fluoroionophores, and nitrodibenzofurans, were used for Zn
2+
 and Ca
2+
 caging.
9-13
 These 
systems, however, require high doses of near-UV light for uncaging, which limits 
biological compatibility and depth penetration in biological systems. Light penetration 
into tissue can be improved with longer wavelengths or 2-photon excitation. However, 
there are limited examples of caging metal ions with visible or NIR light. One example 
by Canto et al. used spiropyran receptors conjugated to single-wall nanotubes (SWNTs) 
for the reversible trapping and release of Zn
2+
 with visible light.
14
   
 Encapsulation within stimulus-responsive nanocarriers is a more generalizable 
approach to metal ion caging/release compared to molecularly caged systems. The release 
no longer depends on the ligand chemistry, enabling the same nanocarrier to be used for a 
variety of different metal ion systems, or even to deliver multiple metal ions 
simultaneously. Another advantage of nanocarriers over molecular cages is that the 
number of metal ions that can be caged is not limited by the valency of the chelator. One 
versatile class of nanocarriers is polymersomes, which are self-assembled bilayer vesicles 
synthesized from amphiphilic diblock copolymers.
15,16
 They provide a large internal 
aqueous environment for hydrophilic encapsulation and a hyperthick membrane for 
hydrophobic encapsulation, and can be surface modified to provide targeting 
capabilities.
17-22
 
 The work presented here specifically utilizes photoresponsive nanoscale 
polymersomes for the encapsulation and delivery of metal ions with a visible light 
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trigger. Previous examples of photoresponsive nano-polymersomes were limited to 
incorporation of UV-active moieties within the diblock copolymer. Cabane et al. 
presented a UV-responsive nano-polymersome containing an o-nitrobenzyl moiety 
between the hydrophobic and hydrophilic polymer blocks, used to encapsulate and 
release small molecular weight dyes and proteins.
23
 There are examples of other types of 
nanocarriers that can be made photoresponsive such as micelles with embedded 2 photon 
active photoswitches, reported by Zhang et al.
24
 
  Previous work done in our laboratory has shown that micron-scale polymersomes 
synthesized from poly(ethylene oxide)-poly(butadiene) (OB29, MW = 3800 g/mol) can 
be made photoresponsive through the addition of dextran in the aqueous core and meso-
to-meso ethyne-bridged (porphinato)zinc(II) dimer, PZn2, in the hydrophobic membrane. 
These vesicles undergo membrane deformation upon irradiation with visible light, as the 
incorporate PZn2 is an effective chromophore in the visible to near-IR region.
17,25,26
 Here, 
we present the extension of this work from micron-scale vesicles to vesicles that are 100 
to 200 nanometers in diameter, a size regime amenable to the use of this system in 
biological applications. Additionally, we demonstrate the ability to tune 
photoresponsiveness of the system with visible light wavelength, irradiation time, and the 
presence of dextran in the core. The system presented here shows efficient encapsulation 
and release of a small molecule, fluorescein isothiocyanate (FITC), and two biologically 
relevant metal ions, Zn
2+
 and Ca
2+
. This work is the first report of nano-polymersomes 
for the encapsulation of metal ions and release with visible light. 
 139 
 
II. Experimental procedures 
 
A. Self-assembly of micron-scale polymersomes 
 Micron-sized polymersomes were synthesized via a thin-film rehydration 
method.
26
 Briefly, OB29 polymer solution (200 µL, 1 mM) in methylene chloride was 
deposited onto the surface of a roughened Teflon square. The film was placed in a glass 
vial and allowed to dry for 16-24 h to evaporate of the organic solvent. An aqueous 
buffer (2 mL) containing the hydrophilic encapsulant in 290 mOsm sucrose was added to 
the glass vial, submerging the polymer film entirely in the buffer. The glass vial was 
capped and placed in a 60 °C oven for 12-16 h. After heating, the glass vial was rapidly 
vortexed for 1 min to yield micron-sized polymersomes. 
 
B. Self-assembly of nanoscale polymersomes 
 Nanoscale polymersomes were made by direct injection of aqueous buffer into a 
solution of DMSO containing polyethylene oxide–polybutadiene (PEO30–PBD46, denoted 
OB29, MW = 3800 g/mol). The final mixture contained 30% DMSO by volume. The 
DMSO-buffer mixture was immediately vortexed for 5 min to promote vesicle self-
assembly. Vesicle size and monodispersity were tuned through polymer concentration, 
aqueous-to-organic volume ratio, and vortex time. To make light-responsive nano-
polymersomes, a 10 mol% solution of PZn2 (2123 g/mol) was added to the DMSO 
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solution prior to vortexing. Dextran (10 kDa) was added to the aqueous buffer to make a 
10 mg/mL solution.  
  
C. Encapsulation and purification 
 For micron-sized vesicles, hydrophilic encapsulants (fluorescently labeled 
oligonucleotides, 5 nmol) were added to the sucrose hydration solution prior to the 
vortexing. The polymersomes were purified to remove unencapsulated dextran and 
fluorescently labeled oligonucleotide by centrifugation in a density step gradient. Before 
centrifugation, the top layer contained the polymersome sample diluted in isosmotic PBS 
and the bottom layer contained a solution of sucrose and density gradient medium (80% 
sucrose/20% Optiprep by volume). The sample was spun at 10,000 RPM for 1 h at 4 ºC. 
The polymersomes migrated to the PBS and sucrose/Optiprep interface and were 
retrieved with a syringe. The polymersome sample was dialyzed against isosmotic PBS 
(overnight, 4 ºC) to remove any remaining dextran, unencapsulated oligonucleotides, and 
Optiprep in 50 kDa dialysis tubes (Thermo Scientific, Rockford, IL). 
 For nanoscale vesicles, hydrophilic encapsulants (dextran and oligo, FITC, or 
metal ions) were added to the aqueous buffer prior to solvent injection and vortexing. 
Fluorescein labeled morpholino (Fl-MO) loaded vesicles were synthesized by adding 5 
nmol fl-MO to the 290 mOsm PBS hydration buffer. FITC-loaded vesicles were 
synthesized with a saturated solution of FITC in 290 mOsm PBS. Ca
2+
-loaded vesicles 
were synthesized with 150 mM CaCl2, and Zn
2+
-loaded vesicles were synthesized with 
 141 
 
150 mM ZnSO4. After vortexing, vesicles were dialyzed against the corresponding buffer 
of equal osmolarity using a 50 kDa molecular weight cutoff dialysis cassette to remove 
free 10 kDa dextran and unencapsulated hydrophilic cargo. Metal ion samples were 
dialyzed against isosmotic NaCl for two days at 4 °C with at least two buffer changes. An 
additional separation step was performed on samples that would be used for release 
studies to ensure that all free encapsulant was removed. A 50 kDa molecular weight 
cutoff Amicon Ultra centrifugal filter was used to separate any remaining free 
hydrophilic encapsulant from the nanovesicles. The vesicles were spun at 10,000 rpm to 
concentrate, and resuspended in buffer for further washes. This process was repeated 
until free encapsulant could no longer be detected in the filtrate via UV/Vis absorbance. 
A representative UV/Vis (Figure 4-1) shows the removal of unencapsulated 
oligonucleotide with an Amicon centrifugal filter. The Abs260 measured in the flow-
through decreases with increasing number of spin/wash cycles. 
 
D. Dynamic light scattering measurements 
 Polymersome size distribution was measured using a Malvern NanoZS Zetasizer. 
Polymersome samples were diluted 10-fold in the corresponding aqueous buffer in 1 mL 
polystyrene cuvettes. Size is reported as intensity %. 
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E. Cryo-TEM measurements 
 Krishna P. Singh Center for Nantechnology: Lacey formvar/carbon grids (Ted 
Pella) were cleaned with chloroform to remove the formvar coating, carbon coated with a 
Quorum Q150 ES carbon coater (Quorum Technologies, UK), and cleaned with 
hydrogen/oxygen plasma for 15 seconds using a Solarus Advanced Plasma System 950 
(Gatan, Pleasanton, CA). The polymersome sample (2 µL) was deposited onto the grid 
and inserted into a cryoplunger (Cp3, Gatan). The sample was blotted by hand with filter 
paper and plunged into liquid ethane. The samples were subsequently transferred to a 
Gatan CT3500TR cryoholder and inserted quickly into a JEOL 2100 HRTEM (JEOL, 
Tokyo, Japan) operating at 200 kV. Images were captured using an Orius SC200 digital 
camera. 
 Electron Microscopy Resource Laboratory: Lacy carbon grids were glow 
discharged for 20 seconds at 25 mA to create a hydrophilic surface. A volume of 3 
microliters of polymersome sample was applied and a thin film was formed by blotting 
the grid with filter paper. Vitreous ice was formed by rapid plunging into liquid ethane 
cooled to -180 °C by liquid nitrogen. Frozen hydrated samples were observed at -178 °C 
in a FEI (Hillsboro, OR.) Tecnai-12 microscope operated at 80 keV at magnifications 
indicated in the figure legends. Images were recorded on a Gatan (Warrendale, PA) US 
1000 2048² CCD camera. All particle measurements were performed in Digital 
Micrograph. 
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F. Cargo release from polymersomes  
 Light-responsive polymersomes (30 µL) were irradiated in a PDMS well placed 
on a 0.17-micron thick glass coverslip. An Olympus FV1000 confocal laser scanning 
microscope equipped with multiple visible laser lines (488, 515, 543, 633 nm) was used 
for irradiation. The sample was centered within the field of view of a 10x air objective 
(Olympus UPlanSApo, NA = 0.40) lens, and subsequently irradiated for 1, 2, 5, or 10 
min without sample evaporation occurring. Positive control release (100% release) was 
achieved through the addition of a surfactant, Triton-X 100, to a final concentration of 
0.1 vol%. Negative control samples (0% release) were kept at constant osmotic strength 
and were not irradiated.  
 
G. Detection of cargo release from nano-polymersomes 
 Fluorescent oligonucleotide (Fl-MO): After irradiation, 25 µL of sample was 
removed from the PDMS well and placed into the filter of a 50 kDa molecular weight 
cutoff Amicon Ultra 0.5 mL centrifugal filter. PBS (100 mM, 75 µL) was added to the 
filter. The sample was centrifuged for 15 min at 10,000 rpm so that the released 
oligonucleotide (6,000 - 10,000 Da) would flow through the filter but all vesicles (intact 
or ruptured) and encapsulated oligonucleotide would remain in the filter. The flow-
through was collected and analyzed for fluorescence using a Cary Eclipse Fluorescence 
spectrophotometer. The sample was placed in a small volume quartz cuvette (40 µL) and 
excited at 494 nm. The emission spectrum was collected from 504 - 650 nm, and 
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fluorescence intensity at 517 nm was used to calculate oligonucleotide release. Positive 
and negative control vesicles were subjected to the same conditions. 
 Fluorescein isothiocyanate (FITC): After irradiation, 25 µL of sample was 
removed from the PDMS well and placed into the filter of a 50 kDa molecular weight 
cutoff Amicon Ultra 0.5 mL centrifugal filter. PBS (100 mM, 75 µL) was added to the 
filter. The sample was centrifuged for 15 min at 10,000 rpm so that the released FITC dye 
(MW = 389.4 g/mol) would flow through the filter but all vesicles (intact or ruptured) and 
encapsulated dye would remain in the filter. The flow-through was collected and 
analyzed for fluorescence using a Cary Eclipse Fluorescence spectrophotometer. The 
sample was placed in a small volume quartz cuvette (40 µL) and excited at 494 nm. The 
emission spectrum was collected from 504 - 650 nm, and fluorescence intensity at 517 
nm was used to calculate FITC release. Positive and negative control vesicles were 
subjected to the same conditions. 
 Ca
2+
: After irradiation, 6.25 µL of sample was removed from the PDMS well and 
placed in a small volume quartz cuvette. A stock solution of Oregon Green 488 BAPTA-
1 hexapotassium salt in water was prepared to 1 µM. Oregon green stock solution (5 µL) 
was added to the cuvette, and the Oregon Green/polymersome mixture was diluted 128-
fold. The sample was excited at 495 nm and the emission spectrum was collected from 
505 to 650 nm. The fluorescence intensity at 523 nm was used to calculate Ca
2+ 
release. 
Positive control vesicles were achieved with the addition of Triton-X 100. Polymersome 
sample (6.25 µL) was added to a small volume cuvette and Triton-X 100 was added to 
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achieve a final concentration of 0.1% v/v. This sample was then diluted 128-fold, and 
analyzed for fluorescence intensity. Negative control vesicles were also diluted 128-fold 
and analyzed for fluorescence intensity, without additional light or surfactant treatment.
 
 Zn
2+
: After irradiation, 20 µL of sample was removed from the PDMS well, 
placed into the filter of a 50 kDa molecular weight cutoff Amicon Ultra 0.5 mL 
centrifugal filter, and diluted to 90 µL. The sample was centrifuged for 15 min and 
10,000 rpm so that the released Zn
2+
 flowed through the filter but all vesicles (intact or 
ruptured) and encapsulated metal ions remained in the filter. The flow-through was 
collected and analyzed for fluorescence using a Cary Eclipse Fluorescence 
spectrophotometer. The sample was placed in a small volume quartz cuvette (40 µL) and 
5 µL of Oregon Green dye was added. The sample was excited at 495 nm and the 
emission spectrum was collected from 505 to 650 nm, and fluorescence intensity at 523 
nm was used to calculate Zn
2+
 release. For positive control vesicles, Triton-X 100 was 
added to the sample before filtering, to a final concentration of 0.1% v/v. Negative 
control vesicles were untreated, but also spun in centrifugal filters. 
 
H. Microinjection into zebrafish embryos 
 Nano-polymersomes were concentrated in a 10 kDa molecular weight cutoff 
Amicon centrifugal filter. Sample volume was concentrated 4-fold from the original 
sample and used for injections with no additional preparation. Zebrafish embryos were 
obtained from the CDB Zebrafish Core Facilty at the University of Pennsylvania 
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Perelman School of Medicine. All embryos obtained were TLF x TLF (WT). All 
injections were performed at the one-cell stage and injected into the cell compartment 
only. A Harvard Apparatus PLI-100 pico-injector was used to inject controlled volumes. 
Injection volume was calibrated to dispense 10 nL per embryo. Embryos were imaged 
with an Olympus FV1000 laser scanning confocal microscope using transmitted light 
imaging, as well as imaged for PZn2. A 10x air objective (Olympus UPlanSApo, NA = 
0.40) was used for single embryo imaging and 4x air objective (Olympus UPlanSApo, 
NA = 0.16) was used for multiple embryo imaging. 
 
I. Porphyrin dimer (PZn2) wavelength shift determination 
 A CRi Multispectral Imaging System, NuanceFX camera attached to an Olympus 
IX81 inverted microscope, was used for measurement of PZn2 emission spectrum before 
and after irradiation. Epi-fluorescence illumination was used for PZn2 excitation with a 
mercury-arc lamp and 530–550 nm band-pass filter. A three-dimensional image cube 
measuring PZn2 emission from 660–720 nm in 3-nm steps was collected by the camera 
through a 10x air objective (Olympus UPlanSApo, NA = 0.40). The PZn2 emission 
spectrum was determined for select regions of interest using the Nuance 2.10 real 
component analysis software. 
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J. Materials 
 PEO30–PBD46 (OB29) was purchased from Polymer Source (Quebec, Canada). 
Oregon Green 488 BAPTA-1 hexapotassium salt was purchased from Life Technologies 
(Grand Island, NY). PBS (10x), DMSO (ACS reagent grade), CaCl2 (dihydrate), ZnSO4 
(heptahydrate), and Slide-a-lyzer G2 dialysis cassettes, were purchased from Fisher 
Scientific (Pittsburgh, PA). Amicon Ultra centrifugal filters were purchased from 
Millipore (Billerica, MA). 
 
 
Figure 4-1. Abs260 measurement of Amicon flow-through for vesicle purification 
Nanovesicles containing oligonucleotide were separated from free-oligonucleotide with an 
Amicon centrifugal filter. The flow-through for each spin/wash cycle was measured for Abs260 
until free oligonucleotide was no longer detectable. 
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III. Results and discussion 
 
A. Thin film self-assembly vs. Direct injection 
 A standard method of vesicle self assembly to maximize vesicle yield and 
monodispersity was developed. To yield micron-sized vesicles, 1 mM of polymer was 
cast onto a thin teflon film, incubated with the aqueous hydration solution, and vortexed 
to promote self-assembly.
26
 To yield nano-vesicles through this same method, self-
assembly is initiated through sonicating instead of vortexing. Although this method 
generated fairly monodisperse vesicles, the yield of vesicles was limited due to the 
amount of polymer that could be dried on the Teflon film. The concentration of polymer 
for the system was limited to 1 mM to achieve a smooth film. 
 To allow for higher concentrations of polymer to maximize nano-polymersome 
yield, a different method of self-assembly was investigated where a solution of polymer 
in DMSO was directly mixed into buffer. This direct injection method has many benefits 
over the thin-film method of self assembly. Primarily, this method allows for the 
incorporation of higher polymer concentrations, limited only by the solubility of the 
polymer in DMSO. By increasing the polymer concentration, the nanovesicle yield was 
significantly increased. Additionally, the polymer drying and hydration solution 
incubation steps were eliminated, shortening the vesicle preparation process. To achieve 
the maximum yield of vesicles, while preserving vesicle shape, size, and monodispersity, 
a variety of different self-assembly conditions were tested.  
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B. Effect of mixing, aqueous-to-organic ratio, and polymer concentration on 
self-assembly of nanoscale polymersomes 
 The effect of mixing was explored first for the direct injection self-assembly 
method. For the initial screening, no hydrophobic encapsulants (PZn2) or hydrophilic 
encapsulants (dextran, cargo) were included in vesicle preparation. The vesicles were 
characterized dynamic light scattering (DLS), and cryo-TEM. Three methods of mixing 
were tested for their effect on vesicle size and monodispersity: stirring, sonicating, and 
vortexing. The first conditions tested were sonicating vs. stirring during the direct 
injection process. For stirred samples, a micro stir bar was placed into a 2 mL glass vial 
and placed on a magnetic stir plate. The organic (OB29 in DMSO) solution was injected 
into the aqueous solution (0.1 M PBS) while stirring. For sonicated samples, the organic 
solution was injected into the aqueous solution in a 2 mL glass vial while sonicating. 
Both samples were infused at a rate of 10 µL/min. The samples were dialyzed to remove 
the DMSO and both samples were characterized by DLS and cryo-TEM. A comparison 
of the two samples is shown in Figure 4-2. Stirring resulted in uniform particles, 
however, the average size of 60 nm is too small for the encapsulation of biomolecules, 
and not ideal for in vivo applications. Although DLS was promising for the sonicated 
sample, showing an average size of 150 nm, cryo-TEM showed a significant amount of 
complex, non-vesicular structures. The aqueous infusion rate was varied between slow 
infusion (10 µL/min) and direct injection, and no difference was observed on DLS or 
cryo-TEM. Direct injection was used for subsequent samples.  
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 Vortexing was also explored as a method promoting self-assembly. Four different 
vortex durations (1, 5, 10, and 20 min) were tested for two different concentrations of 
polymer. A 1 mM solution of OB29 in DMSO was directly injected into PBS in a glass 
vial. The vial was immediately capped and each sample was continuously vortexed. The 
same series of samples were also made for 3 mM OB29 in DMSO. The samples were 
dialyzed to remove DMSO and then analyzed by DLS. A clear trend was seen for both 
polymer concentrations as shown in Figure 4-3. After 1 min of vortexing there were two 
peaks, likely representing both micelles, and unassembled polymer. As vortex time 
increased these peaks converged to one peak centered around 100 nm. There was no 
significant change after 5 min, indicating that the self-assembly process was complete. 
These samples were also analyzed by cryo-TEM (Figure 4-4) to determine the effect of 
vortex time on morphology. Consistent with DLS, the 1 min vortex sample showed a 
significant amount of micelle formation. The 5, 10, and 20 min vortexed samples showed 
unilamellar, monodisperse vesicles, with very limited presence of non-vesicular 
structures.  
 Another variable in the direct injection self-assembly process was the ratio of 
organic-to-aqueous solvent. Previous samples were made with 30% v/v DMSO in buffer. 
This percent was varied from 10, 30, 50, and 70% for four different polymer 
concentrations in DMSO. The vesicles were dialyzed to remove DMSO and analyzed 
with DLS and cryo-TEM. Figure 4-5 shows the negligible effect that the organic-to-
aqueous ratio had on vesicle size determined by DLS for 1, 1.5, 2, and 3 mM OB29 
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concentrations. However, when these samples were visualized by cryo-TEM (Figure 4-6) 
a very significant difference in morphology was seen. Although unilamellar vesicles were 
present in all samples, 10% and 70% DMSO had a large amount of non-vesicular 
structures, such as worms and micelles. The 30% and 50% DMSO samples both yielded a 
large amount of uniform, unilamellar vesicles of the desired size. Because DMSO 
removal is necessary for biological applications, 30% DMSO was a better choice for this 
system. 
 The effect of concentration on vesicle size was also explored. Figure 4- shows a 
slight difference in vesicle size between 1, 1.5, 2, and 3 mM OB29 in 30% DMSO. 
Vesicles prepared with 1 mM and 3 mM OB29 resulted in slightly smaller vesicles. 
Vesicles prepared with 1.5 mM and 2 mM OB29 resulted in vesicles of a more desirable 
size, making these concentrations a reasonable choice for vesicle preparation. 
 Thorough self-assembly characterization resulted in the following optimized 
vesicle preparation conditions: Direct-solvent injection of 30% DMSO containing 1.5 - 2 
mM OB29 into 0.1M PBS, immediately capped and vortexed for 5 min, followed by 
dialysis to remove DMSO. To make these vesicles light-responsive, 10 mol% PZn2 was 
added to the polymer in DMSO solution. These vesicles were dialyzed and imaged with 
cryo-TEM to confirm the desired morphology and size with the addition of a 
hydrophobic encapsulant. Figure 4-8 shows vesicle size and morphology using the 
optimized conditions. 
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Figure 4-2. Effect of  stirring vs. sonicating during nanovesicle self-assembly 
A comparison of nanovesicles prepared with stirring vs. sonicating. Stirred samples resulted in 
uniform vesicles < 100 nm in diameter. Sonicated samples resulted in larger vesicles and 
asignificant amount of non-vesicular wormlike structures. 
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Figure 4-3. Effect of vortex time on nano-vesicle size 
DLS showing the effect of vortex time on vesicle size. Vesicles were prepared by directly 
injecting OB29 in 30% DMSO into 0.1 M PBS followed by immediate vortexing. Vesicle size 
converged by 5 min for both concentrations. 
 
 
Effect of  
vortex time 
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Figure 4-4. Effect of vortex time on nano-vesicle morphology 
Cryo-TEM images showing the effect of vortex time on vesicle morphology. Vesicles were 
prepared by directly injecting OB29 in 30% DMSO into 0.1 M PBS followed by immediate 
vortexing. A) 1-min vortexing resulted in a large number of micelles. B)  5-min vortexing 
resulted in uniform, unilamellar vesicles. C, D) 10-min and 20-min vortexing showed no 
significant change from 5 min. 
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Figure 4-5. Effect of organic to aqueous ratio on nano-vesicle size 
DLS measurements showing no significant effect on organic (OB29 in DMSO) to aqueous (0.1 M 
PBS) ratio. Legend % represents percent DMSO in final solution. 
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Figure 4-6. Effect of organic to aqueous ratio on vesicle morphology  
Cryo-TEM images showing the effect of organic to aqueous ratio on vesicle morphology. A) 10% 
final DMSO resulted in vesicles and worms. B, C) 30% and 50% final DMSO resulted in 
uniform, unilamellar vesicles. D) 70% final DMSO resulted in vesicles and worms. 
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Figure 4-7. Effect of polymer concentration on nanovesicle size 
DLS measurements showing differences in vesicle size with varying OB29 in DMSO 
concentration. 
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Figure 4-8. DLS and cryo-TEM showing final conditions for nanovesicle self-assembly 
Vesicles prepared with DMSO containing 1.5 mM OB29 and 10% w/w of PZn2, directly injected 
into 0.1 M PBS followed by 5 min of vortexing. Vesicles were dialyzed to remove DMSO. A) 
Size distribution of polymersomes in (B) as determined by dynamic light scattering. B) cryo-
TEM image of polymersomes containing 10% PZn2 in the membrane. 
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C. Nanovesicle rupture determined by PZn2 emission shift 
 The meso-to-meso ethyne-bridged (porphinato)zinc(II) fluorophore (PZn2, Figure 
4-9) has been previously reported to undergo an emission shift in response to its 
environment; deformation of micron-scale OB29 vesicles was monitored by this 
approach .
27
 Encapsulation within the nano-polymersome membrane restricts the mean 
PZn-PZn torsional angle, causing PZn2 to adopt a more planar structure and red-shift in 
emission compared to emission in solution. Upon irradiation and membrane 
destabilization, PZn2 encounters more free volume within the membrane and can increase 
its mean torsional angle, causing a blue-shift in emission relative to the unirradiated 
state.
27
 Thus, PZn2 emission wavelength is a convenient and accurate way to monitor 
membrane destabilization. We expect PZn2 to maintain a similar conformation within 
nano-polymersomes as micron-polymersomes because the thickness of the hydrophobic 
membrane does not change.
28
     
 To probe nanovesicle rupture, vesicles were irradiated with visible light for 
increasing amounts of time (1, 5, 10, 20 min). A multispectral imaging camera was used 
to determine an aggregate PZn2 emission of the bulk polyersome-containing solution 
after each irradiation period. PZn2 emission blue-shifted from 714 nm to 705 nm with 
increasing irradiation times (Figure 4-10A), consistent with PZn2 adopting a more twisted 
structure in a less conformationally restricted environment (Figure 4-10B). The quantum 
yield for release was not determined, however, 20-min irradiation correlated well with a 
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positive control release sample where a surfactant, Triton-X 100, was added to fully 
destabilize the membrane. These data were consistent with vesicle rupture.  
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Figure 4-9. Structure of meso-to-meso ethyne-bridged (porphinato)zinc(II) dimer (PZn2) 
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Figure 4-10. Membrane deformation detected by PZn2 emission blue-shift.  
A) The emission spectra for PZn2 in nano-polymersomes were detected as function of irradiation 
time. The emission blue-shifted with increasing irradiation time. B) Normalized ratio of I714 
(planar) to I705 (twisted). 
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D. Encapsulation and release of oligonucleotides 
 To confirm that oligonucleotides preferentially reside in the aqueous core, initial 
loading experiments were explored in micron-sized vesicles and confocal laser scanning 
microscopy (CSLM) was used for imaging. A 25-mer fluorescently labeled antisense 
morpholino (fl-MO) was purchased from Gene Tools (Philomath, WA) and loaded in 
micron vesicles according to methods described in section 4II-A and 4II-C. Micron-sized 
vesicles were imaged, and distribution of fluorescence was seen throughout the aqueous 
core as shown in Figure 4-11. A dual-loading experiment was performed to confirm 
localization of PZn2 in the hydrophobic membrane and a 25-mer Alexa-488 labeled DNA 
in the aqueous core (Figure 4-12). Finally, control vesicles containing no aqueous or 
hydrophobic encapsulants were imaged to confirm fluorescent signal was due to PZn2 
and fluorescently labeled oligos (Figure 4-13). 
 Nanovesicles containing fl-MO were prepared by including 5 nmol of fl-MO in 
the aqueous solution (0.1 M PBS) prior to the self-assembly process. PZn2 (10 mol%) and 
10k dextran (10 mg/mL) were included to make the vesicles light-activatable. To 
quantify fl-MO loading in nanovesicles, unencapsulated fl-MO was separated and 
quantified. After self-assembly, the vesicles were dialyzed against 0.1 M PBS in a 3.5 
kDA molecular weight cutoff dialysis cassette to remove DMSO, but retain all fl-MO. 
Unencapsulated fl-MO was then removed with a 50 kDa molecular weight cutoff Amicon 
centrifugal filter. Quantification of fl-MO with Abs260 revealed a total fl-MO 
encapsulation of 0.58 nmol, or 11.5% of the starting quantity. This quantity was 
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corroborated with quantification by the fluorophore with a standard curve. Attempts were 
made to increase fl-MO loading efficiency by increasing the starting quantity, however, 
this resulted in similar absolute loading.  This suggests that the maximum amount of 
loading is governed by vesicle size and number, not by starting concentration. 
 Release experiments were done to determine the amount of fl-MO released as a 
function of irradiation time. fl-MO-loaded nanovesicles were placed in a PDMS well and 
irradiated with confocal lasers (488, 515, 543, 633 nm) for increasing amounts of time (0, 
2, 10, 20 min). Positive (0.1% Triton-X 100) and negative (untreated) control samples 
were also prepared. Fl-MO was removed by sizing with an Amicon centrifugal filter. The 
released fl-MO was quantified by fluorescein emission (Figure 4-14). The percent release 
was calculated by dividing the fluorescence of the irradiated sample by the fluorescence 
of 100% release (Equation 1). A positive control was used as 100% release, and a 
negative control was subtracted out as background. These values were corrected for 
minor variations in volume. Percent release was plotted as a function of time, shown in 
Figure 4-15.       
 
Equation 1: 
                           
                       
      
  
 Within the first 2 min of irradiation, 9% of fl-MO was released. Release with time 
was fairly linear, and after 20 min of irradiation this release increased to 61%. Although 
this was a significant fractional release, the absolute quantity of fl-MO released after 20 
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min of irradiation was approximately 350 pmol per 1 mL sample. To make this feasible 
for in vivo antisense applications, this sample would have to be concentrated 1000-fold to 
1 µL, risking particle aggregation. Thus, morpholino encapsulation and release with 
nano-polymersomes was not pursued further. 
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Figure 4-11. Encapsulation of fluorescein-labeled MO in micron vesicles 
A) Fluorecein emission from fl-MO and B) DIC image. Scale bar represents 10 µm. 
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Figure 4-12. Dual encapsulation of Alexa 488-DNA and PZn2 in micron vesicles 
A) DIC image, B) Alexa-488 emission from DNA, and C) PZn2 emission. Scale bar represents 10 
µm. 
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Figure 4-13. Unloaded micron vesicles 
A) PZn2 emission channel and B) DIC image. Scale bar represents 10 µm. 
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Figure 4-14. Fluorescence intensity of fl-MO as a function of irradiation time 
Nano-vesicles containing fl-MO were irradiated for increasing amounts of time. Released fl-MO 
was separated out and quantified via emission at 517 nm. A positive control (0.1% Triton-X) and 
negative control were also analyzed for fl-MO release. 
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Figure 4-15. Release curve for fl-MO loaded nanovesicles 
Fractional fl-MO release was calculated as a function of irradiation time with 488, 515, 543, and 
633 nm according to Equation 1. Release percentages were calculated comparing full (100%) 
release with a surfactant (0.1% Triton-X). 
 
 
 
 
 
 
 
 
 
 
 
0% 
10% 
20% 
30% 
40% 
50% 
60% 
70% 
0 5 10 15 20 25 
%
 R
el
ea
se
 
Irradiation time (min) 
 171 
 
E. FITC loading and release from nanovesicles 
 To further probe this photoresponsive nano-polymersome system, a model 
hydrophilic molecule, fluorescein isothiocyanate (FITC), was encapsulated. The 
photoresponse of the nano-polymersomes was tuned by the irradiation time, presence of 
dextran, and wavelength of light. Our previous work developed a generalized system for 
tuning the photoresponsiveness of micron-sized polymersomes.
26
 It was determined that 
including a high molecular weight dextran in the aqueous core of polymersomes and 
PZn2 in the membrane was required for vesicle rupture. It was concluded that dextran 
likely interacts with the inner leaflet of the bilayer membrane and reduces its elasticity, 
whereas PZn2 (a highly absorptive chromophore with modest quantum yield) functions to 
generate heat upon irradiation. The combined effect produces an asymmetric thermal 
stretching of the membrane, ultimately causing rupture.
26
 We translated these findings to 
photoresponsive nanovesicles, with a modification to encapsulate lower molecular weight 
dextran (10 kDa) in the aqueous core due to the smaller luminal volume of nano-
polymersomes. It was also hypothesized that the membrane could be destabilized from 
the thermal expansion caused by PZn2 alone because of the increased curvature of 
nanovesicles. 
 To assess the role for dextran, FITC was loaded into the aqueous core of nano-
polymersomes with and without the inclusion of 10 kDa dextran in the aqueous core. 
Both systems were irradiated with either 488-nm laser, or via combination of four visible 
wavelength lasers (488, 515, 543, 633 nm). The combination of four lasers was chosen as 
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an extension of our previous work with micron-vesicles, corresponding to several 
absorbance features of PZn2 in the polymersome membrane. The 488-nm laser was 
chosen as a single irradiation source as PZn2 absorbs maximally near this wavelength. 
The release curves for these four conditions (+/- dextran, 488 nm/all lasers) are shown in 
Figure 4-16. As expected, percent release (calculated from Equation 1) was identical 
within experimental error when using 488 nm only (Figure 4-16B) vs. the combination of 
visible lasers (Figure 4-16D). This provided additional evidence that vesicle rupture was 
due to PZn2 absorption and not a non-specific effect of irradiation, as the combined laser 
power was significantly greater than 488 nm alone. As hypothesized, due to the increased 
curvature, nano-polymersomes ruptured without dextran (Figure 4-16A, 4-16C), contrary 
to the previous micron-vesicle polymersome system. Nonetheless, dextran-loaded 
nanovesicles consistently exhibited higher % release under all conditions tested (Figure 
4-16).  Nano-polymersomes were also prepared without PZn2 and dextran, and maximum 
irradiation of these vesicles resulted in negligible FITC release (Figure 4-17), which 
confirmed the need for PZn2. 
 These four conditions (+/- dextran, 488 nm or all lasers) provided a versatile 
system that can be adapted to a variety of different experiments depending on factors 
such as laser availability and desired amount of cargo release. To better understand the 
mechanism of rupture, nano-polymersomes were imaged with cryo-TEM before and after 
irradiation (Figure 4-18). Figure 4-18A shows a large population of uniform, unilamellar 
vesicles before irradiation. After irradiation, a variety of non-vesicular structures were 
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present (Figure 4-18B). These images suggest a rupture mechanism where the membrane 
buckles and folds over itself, or is disrupted and reassembles. The mechanism is further 
corroborated by DLS, showing no significant change in size post-irradiation. The cryo-
TEM images also provide insight as to why the release curves plateau without reaching 
100% release. Figure 4-18B shows a large number of vesicles that reassembled after 
membrane deformation. It is likely that the entire contents of the vesicle does not get 
released prior to reassembly. 
 
F. Loading and releasing metal ions with photoresponsive nano-
polymersomes 
 To demonstrate the versatility of this system, encapsulation and release 
techniques were applied to two metal ions with importance in cellular processes. Ca
2+
 or 
Zn
2+ 
was incorporated into the aqueous core
 
of nano-polymersomes without any changes 
to the direct-injection self-assembly process and the hydrodynamic diameter was 
measured to confirm self-assembly (Figure 4-19). These vesicles were prepared both with 
and without 10 kDa dextran and subjected to varying irradiation times with 488-nm laser. 
Figure 4-20 shows release curves for Ca
2+
 (A) and Zn
2+
 (B). Both metal ions were 
successfully loaded and released from nano-polymersomes, with maximum release 
occurring for both ions after 10-min irradiation. Consistent with FITC photo-release, both 
metal ions were released from nano-polymersomes not containing dextran in the aqueous 
core, with a slightly lower fractional release. The concentration of Ca
2+
 after vesicle 
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rupture was determined to be 757 µM from vesicles containing dextran, and 428 µM 
from vesicles without dextran. The concentration of Zn
2+
 after vesicle rupture was 35 µM 
with dextran and 11 µM without dextran. This was determined by full release from 
vesicles with Triton-X 100 and quantified via corresponding Oregon Green-488 
calibration curves. The average number of ions per vesicle was calculated to be 70,000, 
assuming a polymer density of 1 chain/nm
2
, which has previously been used to calculate 
vesicle number.
29
 Although the concentration of loaded Zn
2+ 
is significantly lower 
compared to Ca
2+
, it is appropriate for biological applications, as the cellular 
concentration of free Zn
2+
 is typically on the picomolar to nanomolar range.
30
 Currently, 
DM-nitrophen (Millipore, Billerica, MA) is the most efficient caged Ca
2+
 chelator, based 
on its high calcium affinity before photolysis, and low affinity post-photolysis. Upon 
irradiation with UV light (365 nm), DM Nitrophen can provide up to a 600 µM jump in 
Ca
2+ 
concentration in living neurons,
4
 however, DM Nitrophen must be employed at 
similarly high concentration. As noted above, the nano-polymersome system can provide 
a similar Ca
2+
 concentration jump, with the added benefits of visible-light release, 
potential for greater biological stability, and the ability to encapsulate tens of thousands 
of ions per vesicle. Further optimization of nano-polymersomes may be possible, for 
example, to accelerate the rate and % yield of metal ion release. 
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Figure 4-16. Release curve of FITC-loaded polymersomes 
Nano-polymersomes containing PZn2 in the membrane were irradiated for various amounts of 
time. A) Polymersomes containing no dextran in the core and irradiated with 488 nm laser. B) 
Polymersomes containing 10 kDa dextran in the core and irradiated with 488 nm laser. C) 
Polymersomes containing no dextran in the core and irradiated with 488, 515, 543, 633 nm lasers. 
D) Polymersomes containing 10 kDa dextran in the core and irradiated with 488, 515, 543, 633 
nm lasers.  
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Figure 4-17. FITC release from nano-vesicles without PZn2 or dextran  
Nano-polymersomes were made without PZn2 in the membrane or dextran in the aqueous core. 
These vesicles were subjected to 20-min irradiation (488, 515, 543, 633 nm), and fluorescence 
intensity was compared to a positive control sample (Triton-X added to 0.1 vol%). Release from 
these vesicles was negligible. 
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Figure 4-18. Morphological change in polymersomes after light irradiation.  
Polymersomes containing 10% PZn2 in the membrane and 10 kDa dextran and FITC in the core 
were imaged with cryo-TEM A) before light irradiation, and B) after 20-min irradiation with 488, 
515, 543, 633 nm lasers.  
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Figure 4-19: Hydrodynamic diameter of metal ion-loaded nanovesicles determined by DLS. 
The hydrodynamic diameter of vesicles containing Ca
2+
 was determined to be 120 nm (blue) and  
vesicles containing Zn
2+
 was determined to be 120 nm (red). 
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Figure 4-20. Release curves of metal ion-loaded polymersomes.  
Nano-polymersomes containing PZn2 in the membrane were irradiated for various amounts of 
time. A) Ca
2+
-loaded polymersomes. B) Zn
2+
-loaded polymersomes.  
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G. Nano-polymersomes in vivo 
 Initial screenings to determine in vivo applicability were explored. Nanovesicles 
were prepared with PZn2 as a hydrophobic encapsulant and Texas-Red dextran in the 
aqueous core. Vesicles were microinjected into zebrafish embryos at the 1-cell stage. 
Immediately following injections, the embryos were imaged to determine vesicle 
dispersion. The embryos were imaged up through 30 hpf. Figure 4-21 A-B shows the 
embryos immediately after injection at the 1-cell stage. Both the PZn2 (A) and Texas Red 
(B) channels show even distribution of the vesicles within the cellular compartment of 
the embryo only. Figure 4-20 C-D shows the embryos at 20 hpf, with PZn2 (A) and Texas 
Red (B) still detectable, and still evenly distributed through the embryo. The embryos 
were monitored up through 30 hpf, and development and survival were comparable to the 
uninjected controls. Embryos injected later than the 1-cell stage did not show even 
distribution of vesicles throughout the cells, showing that the vesicles were not efficiently 
distributed through cytoplasmic streaming, rather incorporated during cellular division. 
 To confirm passive uptake of nano-polymersomes in cells, uptake studies were 
performed. Nano-vesicles prepared with PZn2 were added to cultured macrophages and 
incubated for four hours. Cells were washed with PBS and imaged for PZn2 emission 
within the cell (Figure 4-22). A z-stack image confirmed uptake within the cell and not 
just adherence to the cell surface.  
 A PZn2 emission wavelength shift experiment was performed in zebrafish 
embryos to probe vesicle rupture in vivo. Nanovesicles (4x concentrated) were 
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microinjected into zebrafish embryos at the 1-cell stage. Confocal microscopy was used 
to confirm nano-vesicle injection and cellular distribution at the 4-cell stage. A single 
embryo was placed in a glass-bottom dish in E3 medium, and irradiated continuously 
with 488 nm with an ROI selected to include only the cellular compartment (rastering the 
ROI for 5 min). Embryos were imaged before (Figure 4-23A) and after (Figure 4-23B) 
irradiation to confirm that PZn2 emission was still detectible, and to confirm that the 
embryo was not damaged in the irradiation process. A NuanceFX multispectral camera 
was used to measure the PZn2 emission wavelength from the cellular compartment only 
before and after 5-min irradiation (Figure 4-23C). An identical wavelength shift was 
observed in vivo as was seen in bulk, confirming vesicle rupture in zebrafish embryos. 
The complete shift to 705 nm was seen with significantly less irradiation time in vivo 
than in the bulk sample (5 min vs. 20 min), likely due to the smaller volume being 
irradiated. 
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Figure 4-21. Confocal images of zebrafish embryos injected with nanovesicles. 
Zebrafish embryos were microinjected with nanovesicles containing PZn2 in the membrane 
(purple) and Texas-Red dextran (red) in the aqueous core. Embryos were imaged at A,B) 1-cell 
stage and C,D) 20 hpf to determine vesicle distribution and embryo viability. Single embryos 
were imaged with a 10x objective and multi-embryo images were imaged with a 4x objective. 
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Figure 4-22. Cell uptake of nano-polymersomes 
Nanovesicles containing PZn2 were incubated with macrophages to confirm passive uptake. Cells 
were imaged after 4 h incubation. 
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Figure 4-23. PZn2 wavelength shift in vivo 
A) PZn2 emission in a zebrafish embryo before irradiation and B) after 5 min irradiation with 
488, 515, 543 and 633 nm. C) The emission spectra for PZn2 in nano-polymersomes were 
detected as function of irradiation time. The emission blue-shifted with increasing irradiation 
time. 
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IV. Conclusion: 
 We reported a visible light-responsive nano-polymersome system capable of 
encapsulating and releasing oligonucleotides, small molecules (FITC) and metal ions 
(Ca
2+
 and Zn
2+
). This system uses PZn2, a hydrophobic porphyrin photosensitizer, 
encapsulated in the membrane to provide thermal expansion and subsequent membrane 
rupture. The inclusion of dextran in the aqueous core was probed for FITC and metal ion 
systems, and shown to increase loading and fractional release. However, release can still 
be achieved without dextran, unlike our previously reported micron-sized 
photoresponsive polymersomes.
26
  
 Morpholino loading and release concentrations demonstrated were not sufficient 
for in vivo knockdown experiments, however, this system could still be useful in 
applications that require lower concentrations of oligo release. Importantly, we 
demonstrated metal ion release at concentrations suitable for cellular applications. Our 
system has many potential benefits over many previously reported caged chelators, 
namely, the use of 488-nm light, and the ability to encapsulate different metal ions 
without the need for modifying metal chelation or changing the self-assembly process. 
The PZn2 emission shift provided a built-in reporter for vesicle rupture, which can be 
useful for confirming spatiotemporal release in biological systems. Additionally, due to 
the broad absorbance spectrum of PZn2, it is feasible to extend future work to releasing 
with near-IR light, as PZn2 has λmax at 714 nm.
17
 Finally, it was demonstrated that 
nanovesicles could be passively uptaken by cells, as well as microinjected into zebrafish 
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embryos with no detectable toxicity. Vesicle rupture in vivo was demonstrated through a 
PZn2 emission shift. 
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Chapter 5 
 
Conclusions and future directions 
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I. Conclusions  
 The development of photoactivatable oligonucleotides has come a long way since 
initial efforts in our lab where we demonstrated RNase H-dependent RNA digestion with 
a light-activated DNA hairpin, and a light-responsive negatively charged peptide nucleic 
acid hairpin for antisense activity in zebrafish embryos.
1-4
 Work presented in this thesis 
expanded these photochemical tools to three new caging methods. A bidirectional photo-
regulated miRNA was designed to control a miRNA antagomir and exogenous miRNA 
with 365 nm light.
5
 A ruthenium-caged morpholino for the photoregulation of antisense 
activity was presented, extending the photoactivation wavelength to the visible spectrum. 
Finally, a visible light-responsive nano-polymersome system was developed for the 
encapsulation and release of a variety of cargo, including metal ions, oligonucleotides, 
and a fluorescent dye. 
 Chapter 2 expanded upon our previously demonstrated caged hairpin design by 
exploring the benefit of one vs. two nitrobenzyl moieties. Incorporating a second 
photocleavable group within the blocking strand achieved a significantly higher Tm prior 
to irradiation, and an overall larger ∆Tm between the photolyzed and caged construct. 
This result was corroborated by remarkably low background activity (2%) prior to 
irradiation due to the number of bases that could be rendered inactive through 
hybridization with the biologically active miRNA antagomir. Additionally, this second 
photocleavable group limited the amount of sequence specificity needed in the design, as 
the near full-length blocking sequence needed little optimization in placement and length 
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to block function. A circular miRNA presented in Chapter 2 was the first example of a 
light-activatable miRNA for “turning on” an exogenous miRNA in vivo.  
 Chapter 3 presented the first example of a ruthenium photolinker, RuBEP, which 
was activated with visible light. RuBEP was designed with two alkyne-containing ligands 
for circularizing a bis-azido oligonucleotide through a Cu(I)-mediated [3+2] Huisgen 
cycloaddition reaction. This Ru photolinker was applied to the circularization of two 
morpholinos targeting early developmental genes in zebrafish, ntl and chd, and antisense 
activity was successfully photomodulated with 450-nm light. Circular designs provided 
benefits over hairpin designs, as the circularization process was nearly sequence 
independent without the need for a blocking sequence. Additionally, the exclusion of a 
blocking sequence avoided the risk of off-target effects upon dissociation. 
 Chapter 4 expanded caging techniques to the design of a light-responsive nano-
polymersome. This design employed a meso-to-meso ethyne-bridged (porphinato)zinc(II) 
dimer, PZn2, encapsulated in the hydrophobic membrane to harvest visible light for 
membrane destabilization. Nano-polymersomes encapsulated a variety of cargo, 
including oligonucleotides, a fluorescent dye, and metal ions. Photoresponsive release 
was tunable with wavelength, irradiation time, and dextran inclusion in the aqueous core. 
Nanocarriers provided a versatile method of caging through encapsulation, as a wide 
variety of cargo can be contained in the aqueous core with no modulation to the self-
assembly process. 
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II. Future directions 
 New methods for caging oligonucleotides will soon make it possible to 
incorporate a small library of caging designs and light-activatable moieties. Having 
various caged oligos that can be photoactivated at different wavelengths will provide a 
method of multiplexing, or controlling multiple oligos sequentially with high 
spatiotemporal resolution. 
 One very promising application for multiplexing can be applied to recently 
published work from our lab by Lovatt and Ruble et al., demonstrating a method for non-
invasively harvesting mRNA from single cells using transcriptome in vivo analysis 
(TIVA).
6
 This method used a hairpin design based on the design presented in Chapter 2 
as well as published RNA bandage designs by Richards et al.,
7
 using a second 
photocleavable moiety in the blocking strand to achieve a large ∆Tm between the pre- and 
post-photolysis construct. The original TIVA design uses two nitrobenzyl moieties, 
which optimally photolyzes with 365 nm light. To realize many potential applications, a 
second TIVA-tag that photolyzes with visible light would be advantageous. Using 
RuBEP as a photolinker to develop circular Ru-TIVA is currently being explored to 
expand the TIVA-tag library, as well as to provide a TIVA construct that can be activated 
with two-photon light (Yeldell et al., unpublished work). By using the first generation 
TIVA-tag
6
 in tandem with Ru-TIVA, sequential pull-down of mRNA, or multiplexing, 
may be achieved.  
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 More generally, a library of ruthenium-based photolinkers spanning the visible 
spectrum will enable multiplexing for a multitude of applications, as RuBEP and future 
Ru photolinkers have the potential to circularize any bis-azido oligonucleotide. 
Additional applications potentially include elucidating gene regulatory systems in living 
model systems, where sequential gene knockdown is necessary to probe function.  
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Appendix A. Crystal structure determination of Ru(bpy)2(3-ethynylpyridine)2(PF6)2 
 
    
 
I. Methods 
Compound C34H26N6P2F12Ru•2½ acetone, crystallized in the Triclinic space 
group P1
_
 with a=11.2159(7)Å, b=12.5550(8)Å, c=18.1382(12)Å, =70.206(3)°, 
=85.323(3)°, =67.450(2)°, V=2216.1(2)Å3, Z=2, and dcalc = 1.581 g/cm3. X-ray 
intensity data were collected on a Bruker APEXII CCD area detector employing graphite-
monochromated Mo-K radiation (=0.71073 Å) at a temperature of 100(1)K. 
Preliminary indexing was performed from a series of thirty-six 0.5° rotation frames with 
exposures of 10 seconds. A total of 2348 frames were collected with a crystal to detector 
distance of 37.6 mm, rotation widths of 0.5° and exposures of 20 seconds:  
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scan type 2    frames 
 19.50 327.79 15.97 36.30 739 
 -20.50 342.55 321.55 -73.06 739 
 -23.00 333.53 158.99 -70.01 64 
 -15.50 340.80 341.11 -63.64 99 
 -25.50 330.51 47.91 -56.95 185 
 -25.50 239.19 209.98 28.88 204 
 -18.00 243.20 310.97 36.30 208 
 27.00 277.79 5.00 57.63 221 
 -10.50 318.39 249.35 52.47 254 
 17.00 322.24 318.36 83.36 114 
 27.00 352.41 83.39 85.83 157 
 -18.00 124.02 292.98 -95.28 588 
 Rotation frames were integrated using SAINT,
3
 producing a listing of unaveraged 
F2 and (F2) values which were then passed to the SHELXTL4 program package for 
further processing and structure solution. A total of 73021 reflections were measured 
over the ranges 1.86  27.54°, -14  h  14, -16  k  16, -23  l  23 yielding 10200 
unique reflections (Rint = 0.0189). The intensity data were corrected for Lorentz and 
                                                 
3
Bruker (2009) SAINT. Bruker AXS Inc., Madison, Wisconsin, USA. 
 
4
Bruker (2009) SHELXTL. Bruker AXS Inc., Madison, Wisconsin, USA. 
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polarization effects and for absorption using SADABS
5
 (minimum and maximum 
transmission 0.6876, 0.7456). 
The structure was solved by direct methods (SHELXS-97
6
). Refinement was by 
full-matrix least squares based on F2 using SHELXL-97
1
. All reflections were used 
during refinement. The weighting scheme used was w=1/[2(Fo2 )+ (0.0907P)2 + 
0.3133P] where P = (Fo 2 + 2Fc2)/3. Non-hydrogen atoms were refined anisotropically 
and hydrogen atoms were refined using a riding model. Refinement converged to 
R1=0.0266 and wR2=0.0630 for 9570 observed reflections for which F > 4(F) and 
R1=0.0292 and wR2=0.0655 and GOF =1.051 for all 10200 unique, non-zero reflections 
and 643 variables.
7
 The maximum / in the final cycle of least squares was 0.002 and 
the two most prominent peaks in the final difference Fourier were +1.120 and -0.826 
e/Å3. 
Table A1-1 lists cell information, data collection parameters, and refinement data. 
Final positional and equivalent isotropic thermal parameters are given in Tables A1-2 and 
A1-3. Anisotropic thermal parameters are in Table A1-4. Tables A1-5 and A1-6 list bond 
                                                 
5
Sheldrick, G.M. (2007) SADABS. University of Gottingen, Germany. 
 
 
7
R1 = ||Fo| - |Fc|| /  |Fo| 
wR2 = [w(Fo
2
 - Fc
2
)
2
/w(Fo
2
)
2
]
½
 
GOF = [w(Fo
2
 - Fc
2
)
2
/(n - p)]
½
 
where n = the number of reflections and p = the number of parameters refined. 
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distances and bond angles. Figure A1-1 is an ORTEP
8
 representation of the molecule 
with 50% probability thermal ellipsoids displayed. 
 
 
 
 
 
 
Figure A1-1. ORTEP drawing of RuBEP with 50% probability thermal ellipsoids. 
                                                 
8
“ORTEP-II: A Fortran Thermal Ellipsoid Plot Program for Crystal Structure Illustrations”. C.K. 
Johnson (1976) ORNL-5138. 
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Table A1-1. Summary of structure determination of [RuBEP](PF6)2 
Empirical formula  C83H82F24N12O5P4Ru2 
Formula weight  2109.63 
Temperature  100(1) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P1
_
  
Cell constants:   
a  11.2159(7) Å 
b  12.5550(8) Å 
c  18.1382(12) Å 
 70.206(3)° 
 85.323(3)° 
 67.450(2)° 
Volume 2216.1(2) Å3 
Z 1 
Density (calculated) 1.581 Mg/m3 
Absorption coefficient 0.522 mm-1 
F(000) 1068 
Crystal size 0.42 x 0.26 x 0.10 mm3 
Theta range for data collection 1.86 to 27.54° 
Index ranges -14  h  14, -16  k  16, -23  l  23 
Reflections collected 73021 
Independent reflections 10200 [R(int) = 0.0189] 
Completeness to theta = 27.54° 99.6 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7456 and 0.6876 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 10200 / 122 / 643 
Goodness-of-fit on F2 1.051 
Final R indices [I>2sigma(I)] R1 = 0.0266, wR2 = 0.0630 
R indices (all data) R1 = 0.0292, wR2 = 0.0655 
Largest diff. peak and hole 1.120 and -0.826 e.Å-3 
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Table A1-2. Refined positional parameters for [RuBEP](PF6)2 
  Atom x y z Ueq, Å
2
 
Ru1 0.506258(11) 0.163868(11) 0.264396(7) 0.01291(4) 
N1 0.65818(12) 0.13185(12) 0.19098(8) 0.0153(2) 
N12 0.45450(12) 0.07306(12) 0.20479(8) 0.0149(2) 
N13 0.57466(12) -0.00632(12) 0.34959(8) 0.0155(2) 
N24 0.35555(13) 0.17812(12) 0.33876(8) 0.0154(2) 
N25 0.57819(13) 0.24338(12) 0.32652(8) 0.0155(2) 
N33 0.41533(12) 0.33223(12) 0.17585(8) 0.0151(2) 
C2 0.75831(15) 0.16753(15) 0.18526(10) 0.0188(3) 
C3 0.85450(16) 0.14474(16) 0.13324(10) 0.0219(3) 
C4 0.84615(17) 0.08520(16) 0.08327(10) 0.0235(3) 
C5 0.74281(16) 0.04878(16) 0.08769(10) 0.0218(3) 
C6 0.65119(15) 0.07173(14) 0.14269(9) 0.0169(3) 
C7 0.54123(15) 0.03182(14) 0.15400(9) 0.0173(3) 
C8 0.52811(17) -0.04635(17) 0.11907(11) 0.0247(4) 
C9 0.42495(18) -0.08374(17) 0.13656(12) 0.0272(4) 
C10 0.33660(17) -0.04140(16) 0.18777(10) 0.0226(3) 
C11 0.35404(15) 0.03707(15) 0.22011(9) 0.0180(3) 
C14 0.68458(15) -0.09937(15) 0.34717(10) 0.0195(3) 
C15 0.71162(17) -0.21890(16) 0.39519(11) 0.0247(4) 
C16 0.62293(18) -0.24480(16) 0.44906(11) 0.0261(4) 
C17 0.51085(17) -0.14999(16) 0.45341(10) 0.0222(3) 
C18 0.48813(15) -0.03161(14) 0.40305(9) 0.0165(3) 
C19 0.36860(15) 0.07434(14) 0.40007(9) 0.0161(3) 
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C20 0.27411(16) 0.07009(16) 0.45418(10) 0.0204(3) 
C21 0.16281(17) 0.17312(17) 0.44612(10) 0.0235(3) 
C22 0.15004(17) 0.27882(16) 0.38419(11) 0.0239(3) 
C23 0.24783(16) 0.27815(15) 0.33221(10) 0.0198(3) 
C26 0.50882(15) 0.35333(14) 0.33424(9) 0.0173(3) 
C27 0.55503(16) 0.40441(15) 0.37742(10) 0.0200(3) 
C28 0.67825(17) 0.33911(15) 0.41461(10) 0.0211(3) 
C29 0.75013(16) 0.22637(15) 0.40647(10) 0.0198(3) 
C30 0.69787(15) 0.18182(14) 0.36276(9) 0.0172(3) 
C31 0.47574(18) 0.52329(17) 0.38143(11) 0.0262(4) 
C32 0.4114(2) 0.62209(19) 0.38320(13) 0.0366(5) 
C34 0.47048(15) 0.41520(14) 0.14776(9) 0.0164(3) 
C35 0.41314(15) 0.52533(14) 0.08664(9) 0.0173(3) 
C36 0.29400(16) 0.55052(15) 0.05305(9) 0.0191(3) 
C37 0.23679(16) 0.46539(15) 0.08154(10) 0.0191(3) 
C38 0.29993(15) 0.35806(15) 0.14190(9) 0.0174(3) 
C39 0.47884(16) 0.60893(15) 0.05965(10) 0.0201(3) 
C40 0.53479(18) 0.67633(17) 0.03667(11) 0.0259(4) 
P1 0.91753(4) 0.07849(4) 0.63543(3) 0.01945(9) 
F1 0.77189(10) 0.10137(11) 0.61329(8) 0.0342(3) 
F2 1.06165(11) 0.05864(13) 0.65717(9) 0.0424(3) 
F3 0.92791(14) -0.04413(12) 0.70349(9) 0.0504(4) 
F4 0.97134(12) 0.00549(13) 0.57550(8) 0.0439(3) 
F5 0.90455(13) 0.20274(12) 0.56596(8) 0.0429(3) 
F6 0.86228(11) 0.15488(12) 0.69372(7) 0.0368(3) 
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P2 0.86742(4) 0.76441(4) -0.00468(3) 0.02104(9) 
F7 0.83036(18) 0.78269(12) 0.07795(8) 0.0564(4) 
F8 0.89749(19) 0.75132(17) -0.08864(9) 0.0644(5) 
F9 0.71659(13) 0.81513(15) -0.02793(10) 0.0695(6) 
F10 0.86397(11) 0.90155(10) -0.04003(7) 0.0306(2) 
F11 1.01548(12) 0.71759(12) 0.01791(11) 0.0554(4) 
F12 0.86992(12) 0.62856(11) 0.03176(8) 0.0373(3) 
C41 0.8714(2) 0.33261(18) 0.77964(12) 0.0307(4) 
C42 1.0085(2) 0.2875(3) 0.75661(19) 0.0539(7) 
C43 0.8319(3) 0.2412(2) 0.84166(13) 0.0412(5) 
O1 0.79828(19) 0.43755(14) 0.75071(11) 0.0501(4) 
C44 0.7925(4) 0.4704(4) 0.2172(3) 0.0285(8) 
C45 0.9341(4) 0.4331(4) 0.2064(3) 0.0467(10) 
C46 0.7225(6) 0.5914(5) 0.2295(4) 0.0436(12) 
O2 0.7350(3) 0.4074(3) 0.21545(17) 0.0437(6) 
C47 0.7960(5) 0.5225(4) 0.2705(3) 0.0266(9) 
C48 0.6794(7) 0.6370(7) 0.2342(5) 0.0403(16) 
C49 0.8510(10) 0.4355(8) 0.2255(5) 0.052(2) 
O3 0.8449(3) 0.5035(3) 0.33352(18) 0.0263(7) 
C50 0.9372(4) 0.4879(4) 0.4842(3) 0.0275(9) 
C51 0.8817(5) 0.4529(4) 0.5634(3) 0.0425(11) 
C52 1.0506(5) 0.5301(5) 0.4789(3) 0.0392(11) 
O4 0.8932(3) 0.4866(3) 0.42707(17) 0.0347(6) 
Ueq=
1
/3[U11(aa*)
2
+U22(bb*)
2
+U33(cc*)
2
+2U12aa*bb*cos +2U13aa*cc*cos +2U23bb*cc*cos] 
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Table A1-3. Positional parameters for hydrogens in [RuBEP](PF6)2 
  Atom x y z Uiso, Å
2
 
H2 0.7632 0.2095 0.2178 0.025 
H3 0.9235 0.1690 0.1319 0.029 
H4 0.9089 0.0698 0.0473 0.031 
H5 0.7349 0.0095 0.0542 0.029 
H8 0.5881 -0.0732 0.0843 0.033 
H9 0.4153 -0.1367 0.1141 0.036 
H10 0.2665 -0.0653 0.2003 0.030 
H11 0.2936 0.0662 0.2540 0.024 
H14 0.7450 -0.0826 0.3117 0.026 
H15 0.7882 -0.2811 0.3914 0.033 
H16 0.6387 -0.3246 0.4816 0.035 
H17 0.4508 -0.1651 0.4898 0.030 
H20 0.2856 -0.0018 0.4957 0.027 
H21 0.0982 0.1713 0.4815 0.031 
H22 0.0766 0.3496 0.3775 0.032 
H23 0.2386 0.3499 0.2911 0.026 
H26 0.4265 0.3972 0.3097 0.023 
H28 0.7113 0.3704 0.4441 0.028 
H29 0.8329 0.1810 0.4302 0.026 
H30 0.7473 0.1059 0.3580 0.023 
H32 0.3608 0.6998 0.3846 0.049 
H34 0.5502 0.3985 0.1700 0.022 
H36 0.2535 0.6231 0.0122 0.025 
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H37 0.1569 0.4803 0.0603 0.025 
H38 0.2613 0.3009 0.1600 0.023 
H40 0.5786 0.7291 0.0187 0.034 
H42a 1.0273 0.3552 0.7214 0.081 
H42b 1.0201 0.2290 0.7310 0.081 
H42c 1.0658 0.2495 0.8027 0.081 
H43a 0.8614 0.2331 0.8922 0.062 
H43b 0.8695 0.1636 0.8335 0.062 
H43c 0.7394 0.2679 0.8392 0.062 
H45a 0.9675 0.3548 0.1992 0.070 
H45b 0.9768 0.4278 0.2521 0.070 
H45c 0.9493 0.4926 0.1612 0.070 
H46a 0.6326 0.6048 0.2359 0.065 
H46b 0.7310 0.6558 0.1848 0.065 
H46c 0.7591 0.5910 0.2757 0.065 
H48a 0.6533 0.6840 0.2689 0.060 
H48b 0.6099 0.6152 0.2253 0.060 
H48c 0.7006 0.6847 0.1851 0.060 
H49a 0.9247 0.3670 0.2547 0.077 
H49b 0.8769 0.4766 0.1757 0.077 
H49c 0.7866 0.4072 0.2171 0.077 
H51a 0.8093 0.4324 0.5583 0.064 
H51b 0.8537 0.5205 0.5827 0.064 
H51c 0.9467 0.3836 0.5994 0.064 
H52a 1.0786 0.5469 0.4262 0.059 
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H52b 1.1208 0.4668 0.5143 0.059 
H52c 1.0229 0.6029 0.4928 0.059 
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Table A1-4.  Refined thermal parameters (U's) for [RuBEP](PF6)2 
  Atom U11 U22 U33 U23 U13 U12 
Ru1 0.01149(6) 0.01408(6) 0.01414(6) -0.00525(4) 0.00267(4) -0.00578(5) 
N1 0.0133(6) 0.0157(6) 0.0157(6) -0.0045(5) 0.0025(5) -0.0053(5) 
N12 0.0145(6) 0.0150(6) 0.0148(6) -0.0042(5) 0.0016(5) -0.0061(5) 
N13 0.0141(6) 0.0169(6) 0.0169(6) -0.0066(5) 0.0008(5) -0.0066(5) 
N24 0.0153(6) 0.0181(6) 0.0154(6) -0.0072(5) 0.0027(5) -0.0081(5) 
N25 0.0160(6) 0.0164(6) 0.0146(6) -0.0047(5) 0.0033(5) -0.0075(5) 
N33 0.0147(6) 0.0161(6) 0.0154(6) -0.0066(5) 0.0031(5) -0.0061(5) 
C2 0.0170(7) 0.0220(8) 0.0192(7) -0.0070(6) 0.0028(6) -0.0095(6) 
C3 0.0163(7) 0.0256(8) 0.0230(8) -0.0052(7) 0.0047(6) -0.0104(6) 
C4 0.0195(8) 0.0262(8) 0.0232(8) -0.0088(7) 0.0089(6) -0.0080(7) 
C5 0.0221(8) 0.0231(8) 0.0214(8) -0.0104(7) 0.0061(6) -0.0081(7) 
C6 0.0153(7) 0.0157(7) 0.0182(7) -0.0049(6) 0.0018(6) -0.0052(6) 
C7 0.0157(7) 0.0174(7) 0.0182(7) -0.0063(6) 0.0017(6) -0.0056(6) 
C8 0.0229(8) 0.0274(9) 0.0298(9) -0.0173(7) 0.0072(7) -0.0103(7) 
C9 0.0282(9) 0.0294(9) 0.0348(10) -0.0196(8) 0.0052(7) -0.0154(8) 
C10 0.0225(8) 0.0247(8) 0.0258(8) -0.0093(7) 0.0029(7) -0.0140(7) 
C11 0.0166(7) 0.0201(7) 0.0180(7) -0.0060(6) 0.0025(6) -0.0083(6) 
C14 0.0156(7) 0.0212(8) 0.0218(8) -0.0071(6) 0.0015(6) -0.0071(6) 
C15 0.0196(8) 0.0190(8) 0.0309(9) -0.0071(7) 0.0000(7) -0.0032(6) 
C16 0.0274(9) 0.0174(8) 0.0291(9) -0.0017(7) -0.0009(7) -0.0085(7) 
C17 0.0221(8) 0.0221(8) 0.0225(8) -0.0044(7) 0.0028(6) -0.0113(7) 
C18 0.0160(7) 0.0194(7) 0.0167(7) -0.0068(6) 0.0013(6) -0.0086(6) 
C19 0.0172(7) 0.0184(7) 0.0159(7) -0.0074(6) 0.0019(6) -0.0090(6) 
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C20 0.0238(8) 0.0232(8) 0.0183(8) -0.0077(6) 0.0056(6) -0.0133(7) 
C21 0.0216(8) 0.0295(9) 0.0246(8) -0.0140(7) 0.0104(7) -0.0126(7) 
C22 0.0197(8) 0.0251(8) 0.0266(9) -0.0131(7) 0.0069(7) -0.0056(7) 
C23 0.0189(8) 0.0198(8) 0.0201(8) -0.0076(6) 0.0034(6) -0.0064(6) 
C26 0.0164(7) 0.0174(7) 0.0169(7) -0.0052(6) 0.0029(6) -0.0061(6) 
C27 0.0222(8) 0.0189(8) 0.0203(8) -0.0082(6) 0.0042(6) -0.0083(6) 
C28 0.0236(8) 0.0224(8) 0.0218(8) -0.0097(6) 0.0009(6) -0.0112(7) 
C29 0.0173(7) 0.0211(8) 0.0202(8) -0.0051(6) -0.0007(6) -0.0076(6) 
C30 0.0162(7) 0.0167(7) 0.0178(7) -0.0052(6) 0.0025(6) -0.0062(6) 
C31 0.0268(9) 0.0264(9) 0.0281(9) -0.0135(7) 0.0001(7) -0.0087(7) 
C32 0.0350(11) 0.0292(10) 0.0446(12) -0.0212(9) -0.0036(9) -0.0021(8) 
C34 0.0151(7) 0.0194(7) 0.0174(7) -0.0088(6) 0.0038(6) -0.0075(6) 
C35 0.0196(7) 0.0177(7) 0.0166(7) -0.0082(6) 0.0067(6) -0.0080(6) 
C36 0.0200(8) 0.0171(7) 0.0172(7) -0.0053(6) 0.0021(6) -0.0042(6) 
C37 0.0161(7) 0.0211(8) 0.0207(8) -0.0088(6) 0.0009(6) -0.0060(6) 
C38 0.0153(7) 0.0188(7) 0.0210(8) -0.0089(6) 0.0033(6) -0.0082(6) 
C39 0.0209(8) 0.0196(8) 0.0193(8) -0.0077(6) 0.0049(6) -0.0068(6) 
C40 0.0298(9) 0.0251(9) 0.0268(9) -0.0100(7) 0.0096(7) -0.0149(7) 
P1 0.01575(19) 0.0244(2) 0.0210(2) -0.01088(17) 0.00422(15) -0.00833(16) 
F1 0.0199(5) 0.0419(7) 0.0526(7) -0.0303(6) 0.0009(5) -0.0113(5) 
F2 0.0166(5) 0.0530(8) 0.0643(9) -0.0304(7) -0.0008(5) -0.0103(5) 
F3 0.0471(8) 0.0362(7) 0.0502(8) 0.0053(6) 0.0052(6) -0.0149(6) 
F4 0.0363(7) 0.0536(8) 0.0534(8) -0.0411(7) 0.0134(6) -0.0111(6) 
F5 0.0426(7) 0.0355(7) 0.0405(7) -0.0020(5) 0.0113(6) -0.0151(6) 
F6 0.0305(6) 0.0582(8) 0.0378(6) -0.0358(6) 0.0084(5) -0.0177(6) 
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P2 0.01733(19) 0.0287(2) 0.0218(2) -0.01123(17) 0.00414(16) -0.01182(17) 
F7 0.1081(13) 0.0372(7) 0.0286(7) -0.0170(6) 0.0303(7) -0.0324(8) 
F8 0.1137(14) 0.0909(12) 0.0411(8) -0.0449(8) 0.0397(9) -0.0807(12) 
F9 0.0283(7) 0.0710(10) 0.0773(11) 0.0349(9) -0.0177(7) -0.0329(7) 
F10 0.0297(6) 0.0302(6) 0.0310(6) -0.0061(5) 0.0064(5) -0.0148(5) 
F11 0.0200(6) 0.0354(7) 0.0984(12) -0.0064(7) -0.0155(7) -0.0078(5) 
F12 0.0438(7) 0.0322(6) 0.0451(7) -0.0163(5) 0.0065(6) -0.0221(5) 
C41 0.0405(11) 0.0273(9) 0.0309(10) -0.0136(8) -0.0054(8) -0.0148(8) 
C42 0.0437(13) 0.0595(16) 0.0807(19) -0.0376(15) 0.0061(13) -0.0310(12) 
C43 0.0648(15) 0.0345(11) 0.0319(11) -0.0191(9) 0.0104(10) -0.0216(11) 
O1 0.0649(12) 0.0273(8) 0.0487(10) -0.0093(7) -0.0069(8) -0.0086(8) 
C44 0.030(2) 0.035(2) 0.0234(18) -0.0038(16) 0.0006(17) -0.0205(18) 
C45 0.033(2) 0.056(3) 0.047(2) -0.0104(19) -0.0049(18) -0.0172(19) 
C46 0.052(3) 0.039(3) 0.051(3) -0.018(3) 0.016(3) -0.029(3) 
O2 0.0426(15) 0.0430(15) 0.0558(17) -0.0174(13) 0.0019(12) -0.0259(12) 
C47 0.030(2) 0.024(2) 0.025(2) 0.0034(18) 0.0004(19) -0.019(2) 
C48 0.038(4) 0.042(4) 0.030(3) 0.003(3) -0.011(3) -0.013(3) 
C49 0.062(6) 0.052(5) 0.042(4) -0.021(4) -0.008(5) -0.018(4) 
O3 0.0254(16) 0.0274(16) 0.0234(15) -0.0020(13) -0.0050(12) -0.0114(13) 
C50 0.0300(16) 0.0191(14) 0.0274(16) -0.0095(14) 0.0036(14) -0.0020(11) 
C51 0.065(3) 0.041(2) 0.028(2) -0.0137(18) 0.014(2) -0.028(2) 
C52 0.046(3) 0.032(2) 0.040(3) -0.010(2) -0.010(3) -0.013(2) 
O4 0.0321(15) 0.0307(14) 0.0386(16) -0.0121(12) 0.0000(12) -0.0082(12) 
The form of the anisotropic displacement parameter is: 
exp[-22(a*2U11h
2
+b*
2
U22k
2
+c*
2
U33l
2
+2b*c*U23kl+2a*c*U13hl+2a*b*U12hk)] 
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  Table A1-5. Bond distances in [RuBEP](PF6)2, Å 
Ru1-N13  2.0595(13) Ru1-N12  2.0617(13) Ru1-N24  2.0660(13) 
Ru1-N1  2.0750(13) Ru1-N33  2.0981(13) Ru1-N25  2.1083(13) 
N1-C2  1.345(2) N1-C6  1.359(2) N12-C11  1.344(2) 
N12-C7  1.362(2) N13-C14  1.345(2) N13-C18  1.363(2) 
N24-C23  1.345(2) N24-C19  1.362(2) N25-C26  1.349(2) 
N25-C30  1.355(2) N33-C34  1.346(2) N33-C38  1.354(2) 
C2-C3  1.384(2) C3-C4  1.384(3) C4-C5  1.388(2) 
C5-C6  1.391(2) C6-C7  1.476(2) C7-C8  1.390(2) 
C8-C9  1.384(2) C9-C10  1.381(3) C10-C11  1.382(2) 
C14-C15  1.383(2) C15-C16  1.387(3) C16-C17  1.380(2) 
C17-C18  1.392(2) C18-C19  1.471(2) C19-C20  1.388(2) 
C20-C21  1.384(2) C21-C22  1.384(3) C22-C23  1.386(2) 
C26-C27  1.398(2) C27-C28  1.395(2) C27-C31  1.438(2) 
C28-C29  1.386(2) C29-C30  1.383(2) C31-C32  1.182(3) 
C34-C35  1.397(2) C35-C36  1.391(2) C35-C39  1.439(2) 
C36-C37  1.385(2) C37-C38  1.383(2) C39-C40  1.187(3) 
P1-F3  1.5831(13) P1-F4  1.5904(12) P1-F6  1.5956(11) 
P1-F2  1.5998(12) P1-F5  1.6021(13) P1-F1  1.6064(11) 
P2-F11  1.5717(13) P2-F8  1.5821(14) P2-F7  1.5907(13) 
P2-F12  1.5967(12) P2-F9  1.5980(13) P2-F10  1.6070(12) 
C41-O1  1.207(3) C41-C43  1.488(3) C41-C42  1.498(3) 
C44-O2  1.205(4) C44-C45  1.490(5) C44-C46  1.504(6) 
C47-O3  1.217(5) C47-C49  1.499(7) C47-C48  1.506(6) 
C50-O4  1.192(5) C50-C51  1.509(5) C50-C52  1.538(6) 
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Table A1-6. Bond angles in [RuBEP](PF6)2, ° 
N13-Ru1-N12 83.17(5) N13-Ru1-N24 78.73(5) N12-Ru1-N24 96.51(5) 
N13-Ru1-N1 97.01(5) N12-Ru1-N1 78.84(5) N24-Ru1-N1 174.11(5) 
N13-Ru1-N33 172.47(5) N12-Ru1-N33 91.25(5) N24-Ru1-N33 96.99(5) 
N1-Ru1-N33 86.80(5) N13-Ru1-N25 93.45(5) N12-Ru1-N25 174.24(5) 
N24-Ru1-N25 87.36(5) N1-Ru1-N25 97.01(5) N33-Ru1-N25 92.52(5) 
C2-N1-C6 118.06(13) C2-N1-Ru1 126.69(11) C6-N1-Ru1 115.21(10) 
C11-N12-C7 118.18(14) C11-N12-Ru1 125.44(11) C7-N12-Ru1 115.65(10) 
C14-N13-C18 118.04(14) C14-N13-Ru1 125.13(11) C18-N13-Ru1 115.42(10) 
C23-N24-C19 117.88(13) C23-N24-Ru1 126.67(11) C19-N24-Ru1 115.45(10) 
C26-N25-C30 117.15(14) C26-N25-Ru1 123.00(11) C30-N25-Ru1 119.83(10) 
C34-N33-C38 117.45(14) C34-N33-Ru1 122.42(11) C38-N33-Ru1 120.04(10) 
N1-C2-C3 123.04(15) C2-C3-C4 118.81(15) C3-C4-C5 119.01(15) 
C4-C5-C6 119.28(16) N1-C6-C5 121.77(15) N1-C6-C7 115.09(14) 
C5-C6-C7 123.14(15) N12-C7-C8 121.53(15) N12-C7-C6 114.77(14) 
C8-C7-C6 123.64(15) C9-C8-C7 119.35(16) C10-C9-C8 119.12(16) 
C9-C10-C11 118.91(16) N12-C11-C10 122.89(15) N13-C14-C15 122.82(15) 
C14-C15-C16 119.12(16) C17-C16-C15 118.79(16) C16-C17-C18 119.60(16) 
N13-C18-C17 121.61(15) N13-C18-C19 114.62(14) C17-C18-C19 123.71(14) 
N24-C19-C20 121.75(15) N24-C19-C18 114.87(13) C20-C19-C18 123.38(15) 
C21-C20-C19 119.82(16) C22-C21-C20 118.42(15) C21-C22-C23 119.33(16) 
N24-C23-C22 122.79(16) N25-C26-C27 123.01(15) C28-C27-C26 118.87(15) 
C28-C27-C31 121.66(16) C26-C27-C31 119.46(15) C29-C28-C27 118.30(15) 
C30-C29-C28 119.51(15) N25-C30-C29 123.16(15) C32-C31-C27 178.6(2) 
N33-C34-C35 122.86(15) C36-C35-C34 118.75(15) C36-C35-C39 121.81(15) 
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C34-C35-C39 119.44(15) C37-C36-C35 118.71(15) C38-C37-C36 119.18(15) 
N33-C38-C37 123.05(15) C40-C39-C35 178.65(18) F3-P1-F4 90.54(8) 
F3-P1-F6 90.85(8) F4-P1-F6 178.55(8) F3-P1-F2 91.13(8) 
F4-P1-F2 90.12(7) F6-P1-F2 90.26(7) F3-P1-F5 178.94(8) 
F4-P1-F5 89.28(8) F6-P1-F5 89.32(7) F2-P1-F5 89.91(8) 
F3-P1-F1 89.77(8) F4-P1-F1 90.64(7) F6-P1-F1 88.97(6) 
F2-P1-F1 178.82(7) F5-P1-F1 89.19(7) F11-P2-F8 91.44(10) 
F11-P2-F7 91.11(10) F8-P2-F7 177.15(11) F11-P2-F12 91.15(7) 
F8-P2-F12 91.85(8) F7-P2-F12 89.35(7) F11-P2-F9 178.68(9) 
F8-P2-F9 88.88(11) F7-P2-F9 88.54(10) F12-P2-F9 90.12(8) 
F11-P2-F10 88.99(7) F8-P2-F10 89.09(7) F7-P2-F10 89.69(7) 
F12-P2-F10 179.04(7) F9-P2-F10 89.74(7) O1-C41-C43 122.0(2) 
O1-C41-C42 121.9(2) C43-C41-C42 116.0(2) O2-C44-C45 121.9(4) 
O2-C44-C46 120.7(4) C45-C44-C46 117.4(4) O3-C47-C49 121.7(5) 
O3-C47-C48 120.6(5) C49-C47-C48 117.7(5) O4-C50-C51 121.7(4) 
O4-C50-C52 120.6(5) C51-C50-C52 117.7(5)   
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Appendix B. Table of Abbreviations 
Abbreviation Definition 
[Ru(bpy)2XY]
n+
 Ru(II) center with two bipyridines and two monodentate ligands 
1-P 1-photon 
2′-F RNA 2′-Fluoro RNA 
2′-OMe RNA 2′-O-methyl RNA 
2-P 2-photon 
3-EP 3-ethynylpyridine ligand 
4-AP 4-aminopyridine 
6-FAM carboxyfluorescein 
BHQ1 black hole quencher 
bpy 2, 2′-bipyridine 
CHANT1 caged hairpin antagomir with 1 photocleavable moiety, targeting let-7 
CHANT2 caged hairpin antagomir with 2 photocleavable moieties, targeting let-7 
chd zebrafish chordin gene 
chd-MO control morpholino targeting chordin 
CIRClet7 circular let-7 miRNA 
CLSM confocal laser scanning microscopy 
DLS dynamic light scattering 
DMNPE (dimethoxy-2-nitrophenyl)ethyl moiety 
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DMT dimethoxytrityl 
FITC fluorescein isothiocyanate 
fl-MO fluorescein labeled morpholino 
GM Göppert-Mayer 
hpf hours post fertilization 
ISC intersystem crossing 
let-7 zebrafish miRNA, lethal-7 
LF ligand field 
LNA locked nucleic acid 
MB molecular beacon 
miRNA micro RNA 
MLCT metal to ligand charge transfer 
MO morpholino 
N3-DNA DNA with single azide modification 
N3-DNA-N3 DNA with two azide modifications 
ntl zebrafish notail gene 
ntl-MO control morpholino targeting notail 
OB29 polyethyleneoxide30 - polybutadiene46 
ONB o-nitrobenzyl photocleavable moiety 
PAGE polyacrylamide gel electrophoresis 
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PL nitrobenzyl photocleavable linker moiety 
PZn2 meso to meso ethyne bridged [bis(porphinato)zinc] 
RISC RNA-induced silencing complex 
RNAi RNA interference 
RuBEP Ru(bpy)2(3-ethynylpyridine)2Cl2 
Ru-cDNA DNA circularized with RuBEP 
Ru-DNA DNA singly clicked to RuBEP 
Ru-cMO Morpholino circularized with RuBEP 
siRNA short interfering RNA 
Sulfo-EMCS N-Ɛ-Maleimidocaproyl-oxysulfosuccinimide ester 
TBTA ([(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine) 
TEAA triethylammonium acetate 
TLF wildtype Tuebingen long fin wildtype zebrafish 
Tu wildtype Tuebingen wildtype zebrafish 
WT wildtype 
 
